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Abstract  
 
Challenges facing the production of new pharmaceuticals include the costs associated 
with recalls from adverse effects and a lack of effective, low-cost model systems for predicting 
them. Three-dimensional (3D) tissue models offer assays that facilitate faster, more robust pre-
clinical screening. These assays require handling multi-sample drug perfusion at cell-viable 
conditions for long term testing and imaging experiments. Current devices do not achieve these 
criteria in a cost-effective manner. Initial findings suggest the device achieves the goal of 
developing a microscope incubator system for drug screening of 3D tissue constructs, presenting 
a viable diagnostic tool for therapeutic screening. 
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1. Introduction  
  
Introducing a new drug to the market costs about $1 billion, and when complications occur, this 
price can inflate to about $11 billion (Herper, 2012). Common complications that occur in the drug 
production process arise from cardiovascular effects, such as arrhythmias and artery disorders, which 
were not discovered through conventional testing. These effects are responsible for about a third of all 
drug discontinuations. To detect these adverse effects, about an extra $10 billion must be spent due to the 
lack of adequate in-vitro testing methods that are available (Laverty, 2011).  
The standard procedure for in-vitro drug screening involves obtaining cells such as 
cardiomyocytes and culturing them in a two-dimensional plate. The cells are then exposed to the desired 
drug compound and periodically analyzed for cellular function under the microscope. The unnatural 
environment of a flat culturing plate limits cell functionality, making drug testing results inaccurate 
(Radisic et al., 2014). Currently, researchers are developing three-dimensional (3D) cell cultures that are 
more accurate models of in-vivo tissues. Cells cultured in 3D have shown to have increased similarity to 
in-vivo tissues in morphology and physiology responding to the three-dimensional environment (Soares, 
2012 & Radisic et al., 2016). These 3D tissue models are beginning to replace conventional culture as 
more accurate drug models.  
In order to screen drugs on tissue models, researchers struggle to maintain consistent 
environmental conditions for their samples. This inefficient process involves cultured constructs moving 
from the sterile culturing room and incubator to the benchtop microscope for imaging and syringe pump 
for drug perfusion. Only short term analysis can be completed while attempting to maintain cell viability, 
negatively affecting the reproducibility an experiment (Hanton, 2007). Devices that could combine the 
incubating culture environment, drug perfusion, and microscope imaging capabilities would make the 
drug testing process more efficient and reproducible.   
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There are many drug perfusion systems on the market that can be used for drug testing. However, 
none of these existing solutions combine the necessary aspects of incubation, perfusion, 3D tissue culture, 
and imaging in a cost-effective manner. The high cost of current devices, such as live cell imaging 
microscopes (~$10,000) or multi-well incubators (~$8,000) do not meet the client needs. A more cost-
effective device should permit long term analysis of cardiomyocyte reactions to a drug of 
interest resulting in a more efficient, accurate method of evaluating the electrical and mechanical 
characteristics of cardiomyocytes in 3D constructs during drug perfusion. This long-term analysis is 
important because cardiomyocytes are known to react sporadically during different stages of development 
which makes them difficult to analyze in a short period of time (Berridge, 2013).  
Professor George Pins' lab, in collaboration with Gaudette Lab, at Worcester Polytechnic Institute 
has been conducting research focusing on the assessment of cardiomyocyte behavior in 3D tissue models. 
Cardiomyocyte seeded fibrin gels can be utilized as a regenerative "cardiac patch" to repair damaged 
heart tissue. Currently, cardiomyocytes are seeded onto composite 3D scaffolds which are made of fibrin 
microthreads and gel. The mechanical and electrical characteristics of these 3D models can be monitored 
using an optical imaging system, which allows for periodic, real-time analysis. This method is not 
intended for long-term monitoring as it does not maintain the cells in their homeostatic physical 
conditions while imaging. Creating a device that would allow for the long-term analysis of these 3D 
scaffolds would allow researchers to accurately examine the behavior of these cardiomyocyte cells when 
introduced to different drugs and therapeutic molecules. Such a device should include a way to control the 
physiological conditions to sustain these cells throughout the microscopic analysis and to allow for 
perfusion.   
The goal of this project is to design and develop a microscope incubator system that can image 
3D scaffolds and/or gel constructs. In order to fulfill this goal, three criteria had to be accomplished. The 
first is for the device to regulate environmental conditions suitable for cell culture. This includes proper 
temperature, CO2, and humidity levels. A control system was developed using a sensors to measure 
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temperature and CO2 interfacing with a control platform. The control system was validated by maintaining 
viable cell constructs for 8 hours on benchtop. Secondly, the device needed to allow for liquid perfusion 
of both drugs and media. This perfusion capability needed to account for both an input and output of 
desired liquids. The perfusion was validated by first observing the distribution of an injected solution, and 
then by dispersal of a live/dead immunofluorescent stain using the system. Lastly, the device needed to fit 
on an inverted fluorescent microscope and allow for continuous imaging of 3D tissue constructs. 
Constructs were stained and imaged in the device for viability and image quality compared to control 
samples without the device. 
In order to begin constructing the final design of this device, alternatives for each compone were 
brainstormed. After which, feasibility studies were conducted to determine which ideas were the most 
viable. These ideas were then combined to create preliminary final designs. After interviewing the clients 
and assessing each design, a final design was chosen and constructed. Every component of this final 
design was then tested in combination to validate the success of the device. 
After final testing the device met the client needs for a microscope incubator. Specifications for 
incubating environment, liquid perfusion, and imaging compatibilities were met as described in the client 
statement. Furthermore, the device reduced the cost compared to existing solutions by an order of 
magnitude. The cost to manufacture the device is around $450, whereas current solutions cost at least 
$5000. Our device presents a cost-effective tool for drug screening of 3D tissue models. With the success 
of our device, the time and cost of pharmaceutical production will be reduced, leading to cheaper and 
more effective drugs reaching the market. 
The following sections present the clinical need for better methods for drug testing of 3D tissue 
constructs comprised of cardiovascular cells as well as a discussion of existing solutions. After 
this literature review, there is discussion of the design team’s project strategy and alternative 
designs. With the objectives defined, design elements were brainstormed and tested to create a final 
design. Validation testing of the final design met all defined objectives. The device maintained a 
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controlled incubating environment, had sterile perfusion into each well, and was able to be imaged for 8 
hours on the microscope. The last section outlines recommendations for this device in the future to further 
its success.  
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2. Literature Review  
2.1 Clinical Need   
As of 2015, the average cost to develop a pharmaceutical drug was $2.6 billion. With inflation 
and failures accounted for, this cost can inflate to about $11 billion (Pharmaceutical Research and 
Manufacturers of America, 2015). This high cost of production raises prices and limits access to 
pharmaceuticals for the public. During both drug trials for development and during the time a drug is on 
the market, many drugs fail due to toxicological concerns causing nearly 30% of all drug discontinuations 
(Laverty, 2011). The foremost cause of drug discontinuations are cardiovascular and hepatic effects 
(Stevens & Baker, 2009). In addition, these cardiovascular effects are often caused by drugs not intended 
for cardiac applications (Minotti, 2010; Mordwinkin et al., 2012).  
One subset of cardiovascular drugs that have adverse effects are class IA antiarrhythmic drugs. 
These drugs block sodium channels in the heart which prolongs repolarization. These antiarrhythmic 
drugs are intended to treat atrial fibrillation and paroxysmal supraventricular tachycardia (Klabunde, 
2010). However, they have been known to prolong the QT interval, the ventricular repolarization, and the 
depolarization of the heart, which can become fatal. This type of heart arrhythmia is associated with 
Torsade de Pointe, a rare heart condition where the waves of the heart are manipulated in such a way that 
they look 'twisted' about the isoelectric axis. It is more likely that a patient has Torsade de Pointe when 
the QT interval is prolonged, and therefore, drugs that have this effect on the heart pose a serious risk for 
users. Between 1990 and 2006, Torsade de Pointe effects caused around a third of drug withdrawals 
(Shah, 2006). Understanding the effects of a drug on the heart, regardless of the drug's purpose, is crucial 
before administering it to patients. (Jatin et al., 2015).    
Drug induced cardiotoxicity does not only apply to cardiovascular drugs. For example, in 1999, 
the drug Vioxx (rofecoxib), a non-steroidal, anti-inflammatory pain medication was released on the 
market. However, its effects on the cardiovascular system were not known, as it was intended for pain and 
its pre-clinical testing was only centered around its ability to relieve pain as well as its effects on the 
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gastrointestinal system. Researchers did not know that the use of this drug would place users at risk for 
heart problems. This is because the drug's cardiac effects were not tested thoroughly.   
Anti-cancer drugs are another example of non-cardiovascular drugs with cardiovascular effects. 
Herceptin (or Trastuzumab) is a drug used to target the human epidermal growth factor receptor 2 (HER2) 
which blocks cell growth. It is used in stomach and breast cancers that overexpress HER2 on their cell 
surfaces (National Cancer Institute, 2014). However, the HER2 pathway has been identified with 
cardiomyocyte survival and differentiation, which leads to heart malfunctions in patients using Herceptin 
(Blomme & Will, 2016). Anti-cancer drugs such as these sometimes pass clinical trials due to their 
immediate need, but a rapid preclinical screening method could possibly circumvent these side effects 
earlier to create better solutions. Table 1 shows how both cardiovascular and non-cardiovascular drugs 
affect the heart. 
Table 1: Summary of adverse cardiovascular effects from select non-cardiovascular drugs (Mordwinkin et al., 2012) 
Trade Name (Generic Name) Indication(s) Black box Warning 
Avandia™ (rosiglitazone)   Type 2 diabetes   Congestive heart failure and 
myocardial infarction   
Herceptin™ (trastuzumab)   Breast cancer   Cardiomyopathy   
Mellaril™ (thioridazine)   Antipsychotic   QT prolongation and TdP   
Sporanox™ (itraconzaole)   Antifungal   Congestive heart failure   
Tasigna™ (nilotinib)   Leukemia   QT prolongation and TdP   
Tikosyn™ (dofetilide)   Antiarrhythmic   Proarrhythmic effects   
  
2.1.1 Problems with Current Drug Approval Process   
Before a pharmaceutical drug reaches the market, it needs to undergo a series of preclinical and 
clinical testing. The preclinical stage involves discovery of a New Chemical Entity (NCE) by a research 
lab and approval for an Investigational New Drug Application (IND) from the FDA. Approval for an IND 
can be achieved once a compound has completed Animal Pharmacology and Toxicology studies and 
developed Manufacturing Information and Clinical Protocols (FDA, 2016d). The compound then moves 
onto clinical trials and testing in humans, first in small groups, then groups up to 3,000 people. The FDA 
states that only 5 out of 5000 compounds reach clinical trials, and only 1 ends up being used 
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commercially (FDA, 2015b). This stringency may seem to be adequately safe, however, the high rates of 
post-market drug discontinuation show the inaccuracy in current screening methods.   
There is a high withdrawal, or discontinuation rate, of drugs after they reach the market. Most of 
these discontinuations are due to adverse cardiovascular effects (Stevens & Baker, 2009). Out of 47 
withdrawn drugs from 1975-2007, approximately 45% of them were due to cardiovascular effects 
(Stevens & Baker, 2009). Drugs that were found to have cardiac toxicity are most often not for cardiac 
applications at all (Minotti, 2010; Shah, 2006). This emphasizes a need for better models to screen drugs 
for adverse cardiac effects before they reach living test subjects and the market.    
2.1.2 Current Preclinical Two-Dimensional Testing Methods   
Preclinical trials of a drug requires testing on two-dimensional (2D) in-vitro models, meaning "in 
glass" (or plastic) (FDA, 2012b). Cell culture methods in 2D use either primary cells, cell lines, or stem 
cells. A major advancement in cell culture is the usage of stem cells which allow for vitality and growth 
found in cells lines while maintaining the genetic stability of primary cells. Both human embryonic stem 
cells (hESCs) and induced pluripotent stem cells (iPSCs) have been differentiated into cardiomyocytes for 
cardiac research. Human-induced pluripotent cardiomyocytes (hPSC-CMs) are easiest to obtain, however, 
their differentiation into mature cardiomyocyte types has not yet been perfected (Piccini et al., 2015). 
Today, hPSC-CMs are used in cardiac drug screening for impedance-based assays, High Content 
Analysis (HCA) assays, and Multielectrode Arrays (MEAs) (Radisic et al., 2016). All cell types used in 
2D culture are generally grown in a monolayer and sometimes in bioreactors.   
Two-dimensional culture has some advantages and disadvantages as a platform for cellular 
research. It allows for basic cytotoxicity studies with human cells without using expensive animal models 
or humans. Being relatively low cost, 2D culture is used today as the first screening method for drug 
compounds. However, this has many limitations when modeling actual in-vivo conditions. The flat, 
plastic surfaces used to hold the cells have mechanical properties that are rarely found in the body. This 
prevents the cells from forming attachment proteins correctly, and prevents cell-cell signaling and cell-
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ECM signaling naturally (Breslin & O’Driscoll, 2013; Ralph & de Lange, 2013). The cell attachments 
made are also only on the edges of the cells since they are sitting between liquid media and hard plastic. 
The lack of gradients, especially oxygen gas gradients, is the reason it is not possible to replicate tumor 
growth and tissues in 2D culture (Smith, 2012; Imamura et al., 2015). For many applications such as 
disease modelling, monolayers and 2D culture are becoming more questionable as models for in-vivo 
systems (Edmonson et al., 2014).   
2D culture is a limited platform especially for drug screening. A critique of 2D culture is its 
approach of "one-gene, one-protein, one-target," where only a few cellular mechanisms can be observed 
on such a small arrangement of cells (Nam, 2014). Such a narrow view of a drug's effect creates 
inaccurate predictions to how it will affect the human body as a whole (Nam, 2014).   
Current preclinical drug screening for determining cardiotoxicity observe the electrophysiological 
and chemical responses of cardiomyocyte cells in the presence of drug compounds. Cardiomyocytes 
create an electrical impulse, or action potential, that coordinates contractions. This action potential can be 
altered by genetic change in the cell, or by molecular interference (Mordwinkin et al., 2012). The ion 
channel that is most commonly affected is the Ether-a-go-go-Related Gene (hERG) (Roy et al., 1996). 
The International Conference of Harmonization (ICH) has presented guidelines for testing for inhibition 
of the hERG ion channel in the S7A and S7B Guidelines (ICH, 2005). When this action potential is 
altered by a drug, the signal becomes uncoordinated which will present itself by changes in an EKG 
signal, such as Torsades de Pointe.   
To test for hERG channel inhibition, there exist assays that measure the action potential using 
electrodes. Cells used as models are hPSC-CMs, or cells over-expressing the hERG channels such as 
Chinese Hamster Ovary (CHO) or Human Embryonic Kidney (HEK) cells (Shukla, 2016). The assays 
that are used today are the automated patch-clamp method and microelectrode arrays (MEAs), which 
excite ion channels by contact with cell membranes to observe their action potentials when a drug is 
introduced (Pradhapan et al., 2013; Danker & Müller, 2014). These methods evaluate the cells on stiff 
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plates with expensive, technical set-ups and low-throughput applications (Mercola et al., 2013). Another 
common problem even with automated with MEAs and patch-clamps is that by acquiring an accurate 
voltage reading the integrity of the cell is at risk due to dialysing (Yajuan et al., 2012).   
Alternatives to MEAs and the patch-clamp methods have been devised for accurate, less 
destructive, high-throughput testing. These include fluorescence assays, ion-concentration assays, and 
receptor binding assays (Radisic et al., 2016). Voltage-sensitive dyes, such as di-8-ANEPPS or ArcLight 
can be used to visually observe ion channel actions and have been found to be non-invasive to cellular 
action potentials (Herron et al., 2012; Leyton-Mange et al., 2014). Binding assays such as hERG-binding 
assays, indicate that a drug compound will bind to the channel and create arrhythmia and are relatively 
cheaper (Yu et al., 2014). Biomarkers can also be used to evaluate cardiotoxicity, such as the release of 
cardiac-specific Troponin (cTnT) and fatty acid binding protein 3 when cardiomyocytes undergo ischemia 
and cell death (Streng et al., 2014; Andersson et al., 2010). There exist many non-invasive cardiotoxicity 
assays that can be used together for high-throughput applications.   
2.1.3 Current Animal Models   
After a drug compound has passed screening through 2D models, the compound is then tested in 
in-vivo animal models. Animals are different than humans in physiology, cellular pathways, metabolic 
pathways, and disease symptoms. This holds true especially for mice, one of the most commonly-used 
models, which have 67 differences with humans in immunological functions (Langley, 2009). These 
differences create discrepancies in the effects certain drugs have on their respective systems. Xenografts, 
where human tissue or organ has been transplanted into an animal model, are an improvement to 
modelling a human system (Visk, 2015). For cardiac applications, the differences in cellular pathways, 
repolarization mechanisms, and heart rates make animal models inadequate to model the human heart. 
(ICH, 2005; Ferric & Radisic, 2016). However, animal models still have a role in preclinical testing for 
the foreseeable future because in-vitro technology still cannot replicate the complexity of a living 
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organism. With better preclinical models, it would be possible to prevent unnecessary, expensive use of 
animal and human models.   
2.1.4 Cardiovascular 3D Models   
Three-dimensional (3D) in-vitro drug screening methods are bridging the gap between 2D culture 
and animal models. As opposed to 2D cell culture, 3D culture allows cells to communicate naturally in 
three dimensions and create topography found in-vivo. The extracellular matrix (ECM) of cells is crucial 
to providing structure, growth, and communication between cells (3D Biomatrix, 2012). When culturing 
cells in three dimensions, cells are able to recreate this ECM structure and behave more naturally (Tibbitt, 
2009 & Lee, 2008). An example of the differences in 3D morphology can be seen in culturing fibroblasts 
(Figure 1). The cellular adhesion and cytoskeleton organization of fibroblasts in 3D culture replicate in-
vivo fibroblasts (Yamada, 2005). Fibroblast cells do not form monolayers in the body, and instead are 
surrounded by ECM forming long, branching processes. In this way, cells like fibroblasts thrive better in 
a 3D environment (Rhee, 2009) and can be used to model human melanoma (Smalley, 2006). By using 
co-culture of different types of cells in 3D methods, it is possible to create more realistic and complex 
tissues in models.   
 
Figure 1: Human fibroblasts cultured in two-dimensional and three-dimensional culture. The morphology and produced by 3D 
culture is much more similar to in-vivo fibroblasts (Yamada, 2005).  
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There remain some limitations to the emerging field of 3D culture. As the size and complexity of 
the 3D construct increase, there needs to be a vascular network or perfusion to prevent cell death at the 
center of the construct. Microfluidics has created some vascular networks that are being used today, and 
there are now 96-well scaffold-free spheroid models (“GravityPLUS,” 2016). 3D culture for drug 
screening will replicate complex in-vivo microenvironments for more accurate drug screening, but what is 
needed in the industry is a device to test them with.   
Because of its influence in clinical drug attrition, one of the most relevant uses for 3D culture is 
for modelling cardiac tissues. Cardiac tissue consists of highly differentiated and ordered cells to 
propagate signals and contract coordinately. The composition of cardiac tissue is 30% cardiomyocytes, 
which provide the contractile motion for beating regularly. These continuously-beating cardiomyocytes 
require an abundance of mitochondria, close cell-cell junctions, and organized myofibrils (Piquereau et 
al., 2013; Soares et al., 2012). The rest of the tissue is predominantly fibroblasts and endothelial cells, 
providing ECM and vascularization respectively. 3D culture allows cardiomyocytes to form more mature 
T-tubules, form less stress fibers, and are easier to co-culture with other cell types (See Figure 2) (Bian et 
al., 2014; Zuppinger, 2016). Aggregates of hPSC-CMs cultured on collagen have also been found to have 
more mitochondria and organized myofibrils, as well as a more entangled ECM than 2D culture (Soares 
et al., 2012).   
 
Figure 2: Isolated chick cardiomyocytes on collagen substrate after 48 hrs. The 2D cultured cells (left) have a "flat, polygonal" 
morphology whereas the 3D cultured cells (right) are more rod-shaped and have formed a close aggregate, indicating cell-cell 
communication. 3D cultured cells were also stained to show they had more mitochondria and myofibrils (Soares et al., 2012). 
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Current 3D culture techniques used in cardiac drug discovery include scaffold-based, hanging 
drop/spheroid, and gels. Scaffold-based 3D culture uses materials like collagen or decellularized matrices 
as a platform for cell growth and is able to re-create the stiffness found in tissues (Nam et al. 2014; 
Kawaguchi et al., 2013; Jacot et al., 2008). The hanging drop, or spheroid, method uses a naturally-
forming cluster of cells as a model for avascular tumors and solid tissues. The diffusion of gases and 
nutrients limits the size of these scaffold-free models, and they lack support and tension for 
cardiomyocyte cell alignment (Radisic et al., 2016; Soares et al., 2012). Gels mimic the ECM of soft 
tissue and are customizable and inexpensive (Tibitt & Anseth, 2009). They can be made of biomaterials 
such as alginate or collagen which provide cellular cues for growth (Hirt et al., 2014). Both gels and 
scaffolds have been used as high-throughput models for cardiac screening, and have found to have high 
cardiomyocyte alignment and contractions (Schaaf et al., 2011; Turnbull et al., 2013). There are other 
emerging techniques being used for 3D culture such as microchips, cellular printing, and bioreactors, but 
they are not as developed for high-throughput drug screening.     
2.1.5 Cardiotoxicity Testing  
When 2D or 3D models are used in testing, there are outlined parameters that a drug could affect 
and should be tested for. One review article groups the various effects on cardiovascular function into 
three categories (Figure 3) (Hanton, 2007). The first category is described as effects on vascular motricity. 
This describes the movement of the vascular vessels. To test if a drug effects this category, vasodilation 
and the reflex activation of the heart can be recorded. If the drug does cause adverse effects, necrosis, 
fibrosis, or heterotrophy would be observed. The next category describes the adverse effects on cardiac 
function. Effects on this category would be identified through observation and measurement of changes in 
arrhythmias and contractility. The last category is described as the direct effect on cardiac structures. 
Drugs affecting this would be indicated again by changes in contractions and also by impairment of flow.   
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Figure 3: Possible Cardiac Effects of Drugs (Hanton, 2007) 
 
As indicated previously, arrhythmias caused by QT prolongation are a common issue that should 
be tested for thoroughly. The ICH in their S7B document outlines testing considerations for QT 
prolongation (ICH, 2005). These considerations can be tested for either in vivo or in vitro. These 
considerations are summarized in Figure 4. Effects on ionic currents, action potentials and causation of 
proarrhythmias can all be observed through changes in contractility of cardiomyocytes in vitro.   
 
Figure 4: QT Prolongation Testing (ICH, 2005)  
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2.2 Existing Solutions   
As indicated previously, when screening drugs, 3D cell models have been found to better 
represent the body's reactions. This accuracy is because 3D systems resemble in-vivo responses better 
than monolayer or 2D cultures (Martinez et al., 2015). By using 3-D models, "early stages of drug 
development has the potential to generate biologically relevant data that will increase the likelihood of 
success for drug candidates in human studies" (Martinez et al., 2015). Despite these models being a more 
accurate representation, the FDA saw a 50% decline in new molecular entities from 2006 to 2010 (Paul et 
al., 2010).   
Many times, fixed endpoint assays are used to study these 3D models, however, regulation of  
"specific molecular processes and cellular phenotypes" with live cells predicts pharmacological reactions 
in cells that are not seen without regulating the cells over time (Isherwood et al., 2011). It is important to 
be able to predict the response of a drug for it to be non-harmful and clinically effective. In order to assess 
the body's response, the cells need to be imaged in real time. Real-time analysis would expedite the 
timeline for drug development, decrease costs, and result in new ways to observe adaptive responses 
(Butcher, 2005).    
Compared to fixed endpoint assays, temporal analysis has many advantages. Below is a list of 
observations that can be made using imaging of samples over time that cannot be determined with 
endpoint assays (Isherwood et al., 2011):   
1. Temporal phenotypic responses   
2. Determination of the end-time for fixed endpoint assays and best times for a dosing schedule   
3. Understanding inconsistent findings from fixed endpoint assays   
4. Identification of adaptive responses   
Currently, there are various products on the market that are geared toward imaging cells in real time. 
These products may be used to collect information from temporal analysis like the observations listed 
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previously. Some products that are used for these applications include live cell imaging microscopes, 
single-welled microscope incubators, and multi-welled microscope incubators.    
2.2.1 Live Cell Imaging Microscopes   
One common method of imaging cells in real time is to utilize a live cell imaging microscope 
(Figure 5). These microscopes help visualize cells in a more natural state by performing a time lapse 
(“Live Cell Imaging Microscopes,” 2015). They come in many different variations, including confocal, 
phase contrast, and fluorescence. On one distributor's website, it was found that there were over 50 
different live cell imaging microscopes on the market from over 15 different suppliers ("Live Cell 
Imaging Microscopes", 2015). They all share similar core features. Live cell imaging microscopes are 
designed to incubate cells and image them at the same time. Most have high quality imaging, are camera 
compatible, and have incubator control to keep cells at desired atmospheric conditions. Although these 
qualities may be very useful in certain applications, they do not allow for drug perfusion of live cells 
while imaging. In order to have the ability for live cell imaging, research labs have few other choices than 
to buy an entirely new, specialized microscope. Overall, live cell imaging microscopes are useful in 
keeping cell samples at ideal conditions during imaging, but they are not useful if drug perfusion is 
desired.   
 
Figure 5: Cytation 5 Cell Imaging Multi-Mode Reader from BioTek Instruments (“Cytation,” 2016) 
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2.2.2 Single Well Incubator for Microscope Stages   
There are devices on the market that fit on microscope stages and also incubate cells (Figure 6). 
These devices are intended to maintain cells at ideal conditions, perfuse them with drugs, and image 
them. This is optimal because researchers can utilize the existing microscopes in their facility. One 
example of this is the QE-1 Quick Exchange Platform created by Warner Instruments. This device has 
one chamber with removable perfusion tubes that can be used to deliver drugs to the cell sample (“35 mm 
Quick Exchange Platform Model QE-1,” 2016). This specific device has been proven effective and has 
been used in research involving the microscopic imaging of living cells (Conn, 2012). The main 
disadvantage to this system, however, is that it only has one chamber. This means that only one sample 
can be tested at a time and does not allow for multiple variables in an experiment. The system is also 
relatively expensive. The cost of the QE-1 with maintenance of the temperature and atmosphere is 
approximately $8,000 (N. Strickland, personal communication, September 11, 2016). In addition, it also 
does not work on all microscopes without special adapters. Magnetic clamps or stage adapters are needed, 
increasing the cost even further and making it more complicated to purchase and use.     
Another similar device called the Coverslip Chamber by Bioscience Tools (“Heated Chambers 
for Coverslips,” 2016), consists of a heated base that can be secured into the stage of a microscope. There 
is an O-ring to seal the cover slip in place. The device is relatively cheap, costing $475. However, 
temperature control and microscope adapters are purchased separately and adds approximately another 
$2000. The device alone does not regulate CO2 or allow for perfusion, although additional adapters can be 
purchased. Another disadvantage is that it would be difficult to test 3D tissue constructs as the sample is 
simply placed in between glass and a coverslip.    
Yu-Li Wang and Nancy M. McKenna, researchers at the Worcester Foundation for Experimental 
Biology in 1988, made their own single well incubator which has similar capabilities as commercially 
available devices. The single chamber is 35 mm in diameter and is made of Plexiglas. Temperature is 
regulated, and the device is heated by an air blower. Humidity is also regulated. CO2 is maintained, 
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however, it must be manually controlled. A constant rate of CO2 enters the device to keeping the level of 
CO2 at 5% due to leakiness which may need to be adjusted periodically. Media must also be manually 
replaced when using this device (McKenna & Wang, 1988).    
 
Figure 6: QE-1 (“Quick Exchange Platform” 2016) (left), Coverslip Chamber (middle), microscope incubator from McKenna & 
Wang (right) 
2.2.3 Multi-Well Incubator for Microscope Stages   
Other devices exist that have multiple chambers (Figure 7). Additional chambers allow for high-
throughput experiments and for controls and multiple experimental groups. However, other issues with 
each of these arise. One device was created for 3D liver tissue. It was a perfused multi-welled system that 
was placed inside of an incubator to regulate temperature and CO2, however, there was no way to image 
the cells in the device (Domansky et al., 2010).   
Another device created by Harvard Apparatus is the Accelerator 1000. This is a multi-well 
imaging bioreactor and incubator that has 4 wells with active perfusion (“Imaging Bioreactor,” 2016). 
Like the QE-1, this device would need adapters for different microscope stages. Although this product 
had a lot of promise, it was never actually made or sold. Other parts and devices could be put together 
from Harvard Apparatus to create a 4 chamber perfusion system, however, it would cost approximately 4 
times as much as the QE-1 alone (N. Strickland, personal communication, September 11, 2016).   
Similarly, the Miniature Incubator, TC-MWP-6, by Bioscience Tools has six wells for imaging 
(“Miniature Microscope Incubators,” 2016). This product is designed for long-term live cell imaging and 
includes CO2 and temperature control, as well as a heated cover to prevent condensation. Although this 
device contains many of the features desired for live cell imaging, the temperature and CO2 controls do 
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not actually come with the device and have to be purchased as attachments. These two controls are fairly 
large and make the resulting cost almost $8000. Another issue is that because a standard 6-well plate is 
used, there is no perfusion into the wells.   
 
Figure 7: Accelerator 1000 (left) and Miniature Microscope Incubator (right)  
2.2.4 Summary of Existing Solutions   
  In looking at all of the existing solutions, there are many aspects of each that would be useful in a 
microscope incubator. The ideal device for long term imaging of live 3D tissue constructs with perfusion 
would act as an incubator in the sense that CO2, temperature, and humidity are controlled. It would also 
be multi-welled and have perfusion tubes. Existing devices have many of these characteristics, however, 
they are missing others. Table 2 summarizes the advantages and disadvantages of each type of existing 
device. The key was determined by utilizing the design goals to compare and contrast potential design 
properties with the current available technology on the market. 
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Table 2: Comparison of desirable qualities of existing solutions 
  
 
2.3 Need Statement 
  The need for a microscope incubator device is driven by the costly, inefficient process required 
to develop pharmaceuticals. This inefficiency is due to a lack of adequate in-vitro models for preclinical 
drug screening, and a tool to screen them quickly. Currently researchers are developing 3D tissue models 
that surpass 2D cell cultures in mimicking in-vitro tissues. These 3D tissue models will present more 
accurate models for drug screening in behaving closer to actual tissues. However, the current process for 
drug screening requires moving samples from incubating, to benchtop perfusion, to imaging which 
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creates inconsistent environmental conditions. Current devices that combine these environments for ease 
of testing are all costly and may not fulfil all requirements for drug screening of 3D constructs. Therefore, 
there exists a need for a low-cost, microscope incubating device for preclinical drug screening of 3D 
tissue constructs. 
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3. Project Strategy  
3.1 Initial Client Statement   
The challenge that was presented to the design team involved creating a device that would keep 
cells alive by maintaining correct atmospheric conditions. The device would also allow for perfusion of 
desired solutions to the cells. In order to create a strategy to approach the challenge, the design team 
determined the objectives and constraints of the project as a whole. The initial statement provided to the 
design team from the client was to:   
"Design, develop, and characterize a universal incubator system that can be used to maintain  
temperature, humidity, and gas levels during imaging while allowing for perfusion of desired 
solutions."   
In Professor Pins' lab, the only existing systems in the lab to keep cells at the correct conditions 
were standard incubators. The cells were grown in an incubator and had to be taken out of the incubator to 
be imaged. This could only be done for short periods of time, so the cells would not die. This also made it 
difficult to actively dose the cells with drugs while imaging to see the effects. After discussion with the 
client, it was determined that the device should incorporate imaging capabilities, drug delivery, and 
incubation, with the focus of supporting cardiomyocyte cells.  
3.2 Stakeholders  
After being presented with the initial client statement, the design team determined their primary 
stakeholders. The stakeholders were the designers, clients, and users (Figure 8). Overall, stakeholders are 
"individuals or organizations who stand to gain or lose from the success or failure of a system" (Nuseibeh, 
2000). The designer's role is to create a design that other stakeholders can benefit from. The clients are 
those who support and sponsor the project, and the users are those who will ultimately use the created 
product. In this project, the designers were the MQP design team, Rachel Connolly, Marianne Kanellias, 
and Heather Stratica. The clients included Professor Pins and Professor Sullivan, who were both involved 
in creating the initial client statement. The users are PhD candidates Megan Chrobak and Katrina Hansen. 
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After determining these stakeholders, interviews were conducted to help determine the initial objectives. 
After more analysis of these initial project requirements, constraints were determined. From these, as well 
as from a quantitative comparison of objectives, the final objectives were determined and the project 
strategy was defined.   
 
Figure 8: Project stakeholder representation 
  
3.3 Initial Objectives   
After meeting with the clients, the design team came up with seven primary objectives that the 
design must meet. These client meetings were led by questions from the design team. The questions and 
outline for the interviews conducted can be found in Appendix A. The objectives were: cost effectiveness, 
cell viability, user friendliness, reproducibility, versatility, imaging capability, and perfusability. Table 3 
has a short description of each of these objectives. These objectives are described and developed further 
in the following sections.   
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Table 3: Description of initial objectives 
Objective Description 
Cost Effectiveness Market value should outweigh production costs.    
Cell Viability Produces environmental conditions for optimal cell growth   
User Friendly Easy to set-up, clean, and maintain and is safe for the user   
Reproducibility Ensures accuracy and precision   
Versatility 
Is adaptable to various microscopes, can be used for scaffold 
and/or gel-based 3D tissue constructs, and allows for 
experimental variables to be modified   
Imaging Compatibility Allows for bright-field imaging through the device   
Perfusability 
Allows for flow into and out of the device and allows for 
diffusion of the perfused liquid to the cells   
 
3.4 Constraints  
After meetings with the clients and advisors to determine the initial objectives, a set of constraints 
were established. There were two main categories of constraints that were created which were biological 
and technical. The constraints are shown and described in Table 4.   
Table 4: Design constraints and their descriptions 
Constraints Description 
Biological 
Sterile 
-Samples cannot be contaminated for 3 weeks  
-Detachable for sterilization  
-Material must be sterilizable  
Biocompatible 
-Choice of materials  
-Doesn't interfere with cell function  
Technical 
Limited Time -Must be completed by the end of D term  
Cost of Materials -$250 per student  
Size of Device 
-Incubation chamber must fit on microscope  
-Full device fits on benchtop  
  
The biological constraints of this project are extremely important because the project involves 
working with cells. In order for the device to be useful, the cells must stay alive and grow. It is important 
to make sure that the device is sterilizable. This way, contamination will not occur. Because the device 
needs to be sterile, this could affect the design. Electrical components and certain materials may not be 
able to be sterilized using some methods which needs to be taken into consideration. The size of the 
device is also affected by this constraint as it needs to fit in the sterilization machines that are in the 
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current laboratories. The chosen material must also be biocompatible so that it does not harm the cells or 
negatively affect the cell's function.  
Technical constraints include time and resources. The design time is limited to working on the 
project for one academic year, which is approximately 8 months. The budget is also only $750. Because 
of limited lab space, the device that is created should also be as compact as possible. The whole device 
should easily fit on a lab benchtop (approximately 2ft by 2ft space) and the incubation chamber must fit 
on the microscope stage (8 in. by 5 in.) or else imaging would not be possible.   
3.5 Final Objectives   
Initial objectives were broken down to gain a better understanding of the goals involved with 
each objective. Initial brainstorming of objectives can be found in Appendix B. Figure 9 is the resulting 
objective tree. The primary objectives are on the left and the branches off of those defined the secondary 
objectives.   
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Figure 9: Objective Tree 
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The primary objectives were rated using a pairwise comparison chart (PCC) to determine their 
importance. Each objective received a score of a 0, 0.5, or 1 when compared to each of the other 
objectives. A "0" indicated it is less important than the other objective, a "0.5" indicated equal 
importance, and a "1" indicated more importance. The resulting score for each objective was then totaled. 
A pairwise comparison was completed by both the design team, client, and users. The designers 
collectively filled out a PCC, whereas, each client and user filled out an individual PCC without the 
knowledge of how the other parties ranked each objective. Table 5 summarizes the PCC for the primary 
objectives. The complete PCC for each individual stakeholder can be found in Appendix C.   
Table 5: Primary pairwise comparison of primary objectives 
Primary 
Objective 
Designers Clients Users Average 
Cell Viability 6  5.5  4.75  5.42  
Imaging 
Compatibility 
4.5  4.5  4.5  4.50  
Reproducibility 4  4  4.5  4.17  
Perfusability 2.5  4  3.5  3.33  
Versatility 3  2  2.75  2.58  
Cost 
Effectiveness 
1  0  0.5  0.50  
User Friendly 0  1  0.5  0.50  
  
The design team, the users, and the clients all indicated that support of cell viability was most 
important. Without the device being able to support the growth and maintenance of cells, there would be 
no use for the device. The second and third most important objectives for all three stakeholders were 
reproducibility and imaging capabilities. If the device could not be used with imaging, observation of 
cellular activity would be difficult. It is also important that the device functions are reproducible because 
if they were not, there would be little validity in any results that were obtained. All three stakeholders also 
rated cost effectiveness and user friendliness as the least important objectives. These were two aspects 
that can be compromised to obtain a working device.   
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After primary objectives were rated, secondary objective PCCs were completed for sub-
categories of cell viability, reproducibility, and versatility. Definitions for each second objective can be 
found in Table 6, Table 7, and Table 8.   
Table 6: Descriptions of secondary objectives for cell viability 
Primary Objective: Cell Viability 
Secondary Objective Description 
CO2 Regulation  Device kept at 5% CO2  
Temperature Regulation  Device kept at 37° C  
Humidity Regulation  Device kept at 90-100% humidity  
O2 Regulation  Device can use N2 gas to lower O2 gas % to desired value   
  
Table 7: Descriptions of secondary objectives for reproducibility 
Primary Objective: Reproducibility 
Secondary Objective Description 
Precise Temperature  Temperature reaches desired temperature within +/- 1°C  
Accurate Temperature  Temperature reading is representative of actual temperature of 
each well  
Precise CO2 Level  CO2 reaches desired percentage with +/- 1 percent  
Accurate CO2 Level  CO2 reading is representative of actual CO2 level throughout  
Regular Contractility  Device does not induce changes in normal cardiomyocyte 
contractility   
   
Table 8: Descriptions of secondary objectives for versatility 
Primary Objective: Versatility 
Secondary Objective  Description  
Adaptable to Many Microscopes  Can be used on many different types of brightfield 
microscopes  
Can be Used for 3D Tissue Culture  Can be used for gel and scaffold based 3D tissue constructs  
Multiple Inputs  Device has many inputs so various solutions can be delivered 
at the same time  
Multiple Wells  Device has multiple wells to increase throughput and to allow 
for experimental variables  
  
The pairwise comparison summaries for these secondary objectives can be found Table 9, Table 
10, and Table 11. The complete PCC for each individual stakeholder can be found in Appendix D. The 
secondary objectives for cell viability indicated that CO2 regulation and temperature regulation were most 
important. This is why only these two aspects of cell viability were analyzed for reproducibility.  
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Table 9: Pairwise comparison of secondary objectives for cell viability 
Secondary Objectives for Cell 
Viability 
Designers Clients Users Average 
Temperature Regulation  3 3 2.5 2.83 
CO2 Regulation  2 1.5 2 1.83 
Humidity Regulation  1 1.5 0.25 0.92 
O2 Regulation  0 0 1.25 0.42 
  
Table 10: Pairwise comparison of secondary objective for reproducibility 
Secondary Objectives for 
Reproducibility 
Designers Clients Users Average 
Accurate Temperature  2 3.5 2.25 2.58 
Precise Temperature  3 3.5 2.25 2.92 
Regular Contractility  4 0 4 2.67 
Accurate CO2  1 1.5 1.25 1.25 
Precise CO2  0 1.5 .25 .58 
   
Table 11: Pairwise comparison of secondary objectives for versatility 
Secondary Objectives for 
Versatility 
Designers Clients Users Average 
Can be used for 3D Tissue 
Culture  
3 3 2.75 2.92 
Multiple Wells  2 1.5 1.75 1.75 
Multiple Inputs  0 1.5 0.5 0.67 
Adaptable to Many 
Microscopes  
1 0 1 0.67 
  
As indicated by the results of the secondary objective PCC for cell viability, CO2 and temperature 
are most important to regulate. After these, humidity is the next most important, and O2 regulation is least 
important. For reproducibility, precise and accurate temperature were determined to be most important. 
Precise CO2, precise flow, and accurate flow all were rated as least important. One discrepancy between 
the stakeholders was with regular contractility. The client found this to be the least important whereas the 
user and designers found this to be most important. For versatility, it is most important to design a device 
that can be used with 3D tissue culture and have multiple wells.   
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3.6 Revised Client Statement  
After analysis of the primary and secondary objectives, further research, and client meetings, the 
design team proposed a revised client statement. The statement is:  
Design, develop, and characterize an incubator system for inverted bright-field or fluorescent 
microscopes that can be used to maintain 3D gel and/or scaffold-based cardiomyocyte constructs 
in a sterile environment at a temperature of 34 - 37°C, relative humidity of 90 - 100%, and a 
CO2 level at 4% - 6%, while also allowing for liquid perfusion and 8 hours of continuous 
imaging in a minimum of six, 35mm wells during pharmacological testing for up to 3 weeks.   
The revised client statement reflects the most important objectives evaluated by the clients and 
users, including cell viability and imaging. The objectives were also further defined with more 
specifications and metrics.  
3.7 Project Approach  
3.7.1 Management Approach  
In order to stay on task and organized, the design team created a management plan for the project. 
To lay out all tasks that need to be completed and by when, a Gantt chart was created. The chart can be 
found in Appendix E and determines a timeline from A-term to D-term. Each week the percent that each 
task is complete was updated.   
Meetings were also an essential part of the management plan. Weekly meetings with the clients 
were held. Each meeting involved a presentation in which the design team reports their progress, new 
findings, and plans for the next week. This was a good opportunity to make sure that the project was on 
track and that the clients were satisfied. Meetings with the user occurred on a need-to-have basis at least 
once per term. Meetings with all members of the design team were multiple times per week. These 
meetings ensured good communication between all stakeholders.  
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3.7.2 Design Approach  
During the design process, the design team used the outlined constraints and objectives to 
brainstorm as many preliminary design ideas as possible. The best designs were chosen and analyzed by 
ranking them on how well they met each objective. This final design was drawn in SolidWorks®. This 
drawing included the correct dimensions and indicated the materials used for each part. Mathematical 
models for the heat transfer and fluid dynamics of the design were completed as well found in Appendix I 
and M. After finalization of the design, materials were ordered to start creating and testing the device. 
Based on testing, the design was modified accordingly.   
3.7.3 Financial Approach  
The design team was given $250 per student, or $750 total by Worcester Polytechnic Institute to 
complete the project. Because there was a limited budget, the design team determine what materials are 
available for use in the lab before anything is purchased. A list of all materials and cost for the final 
design was created to make sure that the team can afford the chosen design.   
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4. Design Process 
After determining the primary and secondary objectives, the design team was able to create a 
block diagram of the final device. This block diagram, seen in Figure 10, was a high level view of 
elements that would be incorporated into the device. In the following sections, the needs and wants as 
well as the functions and specifications of the final device are determined. Determination of these allowed 
the design team to adapt this vague block diagram and create a specific final model.   
 
Figure 10: Device Block Diagram 
  
4.1 Needs Analysis  
Based on the final objectives and the revised client statement, the design team determined the 
needs and wants of the design. A list of requirements based on how to meet the objectives was created. 
These requirements were then classified as either a need or want. This classification was determined 
based on the primary and secondary objective PCCs.  A need required for the design to be successful. 
Wants are not required for the design to be considered a success in terms of the scope of the project. 
Objectives that received a higher importance resulted in needs. Objectives with lower importance resulted 
in wants. Table 12 is a list of the needs and wants with a short description of each.   
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Table 12: Design needs and wants 
Needs   Definition   
Image-able   Ability to image through without losing clarity   
Biocompatible   Ability to not interfere with the live cells that would be incubated in the 
design   
Perfusable   Ability to perfuse drugs through wells   
Multi-well   Ability to run multiple experiments at once with more than one well 
available   
Sterility   Ability to be sterilized and maintain sterility   
Temperature control   Ability to sense and control temperature of design to the users liking   
CO2 control   Ability to detect and control CO2 within the design to the users liking   
Support 3D tissue 
constructs   
Ability to support common 3D tissue constructs   
Wants   Definition   
Humidity control   Ability to sense and control the humidity within the device   
O2 control   Ability to sense and control the amount of O2 within the device   
Digital display/memory   Ability to digitally display and record all measurements obtained from 
the device   
Electrical stimulus   Ability to deliver an electrical stimulus of choice to live cells within the 
device   
Wireless control   Ability to control all aspects of the device wirelessly   
Temperature gradient   Ability to allow for a difference in temperature across the entire device   
  
4.1.1 Design Needs  
Because cell viability was the highest ranked objective, maintaining atmospheric conditions to 
keep cells alive was essential. Based on the secondary objective rankings for cell viability, CO2 control 
and temperature control were most important. Therefore, CO2 and temperature controls must be 
established as the cells would not survive without the correct levels. CO2 must be kept at 5% because 
when it below this level, the culture medium becomes acidic which is unsuitable for cell growth. It is also 
necessary to keep the device at body basal temperature of 37°C. To ensure cell viability, the device must 
also be sterile and biocompatible, so cells are not contaminated during the experiment.  
Being able to take images of the cells is essential so data about cellular responses can be 
recorded. In addition, in order to actively see how different drugs affect live cells, there needs to be 
perfusion through the wells. Based on the secondary PCC for versatility, it was most important to be able 
to support 3D cell cultures and to have multiple wells. 3D cell cultures better mimic the natural 
environment for a cell which leads to results that are a more accurate representation of what would 
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happen in the body. Having multiple wells is needed so that there is the opportunity for variables in the 
experiments that are run.  
4.1.2 Design Wants  
Wants were determined by extracting them from the objectives that were indicated to be less 
important based on PCCs and through discussions with the user and client. Based on the secondary 
objective PCC for cell viability, control of humidity and O2 were less important to achieve. Although not 
needed, it is desired that humidity reaches 90-100% relative humidity. Maintenance of the correct O2 level 
can be controlled by the addition of N2 gas to displace the correct amount of O2.   
For usability, a digital display and wireless control would be nice to have but are not necessary, 
as the user friendliness objective was scored very low. A digital display would help to make sure the 
device is working properly and wireless control could be used to monitor the device at all times even 
when the researcher is not in the laboratory space.   
Electrical stimuli and a temperature gradient are aspects that would increase the types and 
amounts of experiments that the device could be used for. However, it is more important to focus on 
completing a working device first, if time allows, add additional aspects.   
 
4.1.3 Needs and Wants Design Matrix  
After clear definition of the needs and wants, a design matrix was set up. The purpose of the 
design matrix was to list design considerations to determine which needs and wants influenced each 
design consideration. Table 13 is the complete design matrix. The needs and wants are listed across the 
top and the design considerations are listed down the left side. An X indicates that either a need or want 
influences a design consideration. For example, the size of the device is influenced by being image-able 
because it must fit on the microscope stage. The table was used to help with identifying how the needs 
and wants influence the specifics of the design.  
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Table 13: Design matrix of needs and wants 
  
4.2 Functions and Specifications  
 Two of the main functions of the device is regulation of temperature and CO2 levels. The device 
should include a heat source that can heat the device to 37°C while evenly distributing the heat within +/- 
1°C. The temperature of 37°C is ideal for cell growth, but cells would not die if slightly outside this 
range. It is more likely that cells will survive if the temperature gets cooler rather than hotter, so the 
device should stay between 34 and 37° (“Temperature,” 2016). This temperature range needs to be 
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Measurement of 
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   X X X        X X 
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CO2 Level 
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Well size X  X X  X  X        
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Control System      X X   X X X X   
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maintained for up to three weeks for experiments, as specified by the users. Finally, heating the device 
should not be detrimental to imaging, such as blocking view of construct.  
For CO2, it is important to keep any air within the device at 5% CO2 (“PH and CO2 Levels", 
2016). Cell culture media contains phenol red, which is a pH-sensitive dye that is cherry-colored if the pH 
is within physiological ranges (around pH 7.4). If there is too little CO2, it exits the media to achieve 
equilibrium, which makes the media too basic and pink/purple in color. Conversely, if there is too much 
atmospheric CO2, it solubilizes in the media creating an influx of acidic H+ ions, turning the media 
orange/yellow. As for specifications for this device, CO2 should be evenly distributed between the wells 
and not exceed a difference of ± 1%. Automatic control systems for both heating and CO2 are an 
important specification as well.  
Although humidity is a want, it is important to specify the appropriate level if it was incorporated 
into the device. Humidity should be between 90 and 100% relative humidity. This level of humidity helps 
keep the cell hydrated and makes sure the media will not evaporate. Oxygen regulation is also a want. In 
typical incubators, oxygen can vary between 15 and 20% (“Lab Manual Magazine,” 2011). However, 
oxygen levels in body tissues are much lower. For example, the oxygen level is 0.5-7% in the brain, 3-5% 
in the uterus, and is 4-12% in the heart. Cells, therefore, grow better with lower oxygen levels (Bates, 
2012). Since cardiomyocytes are the focus of the device, it would be desirable to be able to have oxygen 
levels be between 4 and 12% by displacing oxygen with nitrogen.   
Another function of the device is being able to take images of the cells within the scaffold. This 
means that the design must have a clear view of the cell construct. The material that is used to construct 
the device must also be clear. The material should have at least 85% transparency and have a refractive 
index lower than 1.52 (“Optical Properties of High Resolution Microscopy,” 2016). The device must also 
fit on the microscope stage. Out of the three inverted light or fluorescent microscopes in the available lab, 
the smallest stage is 8" by 5". This means the device should not exceed this size, and would be able to fit 
on other inverted microscopes with the same or larger stages.   
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Another function of the final device is being able to image 3D tissue constructs. Gel and scaffold 
based 3D constructs can be various shapes and sizes depending on their purpose. For testing purposes, the 
scaffold that is currently used in Pins' lab will be used. This scaffold consists of fibrin microthreads 
aligned in parallel in a gel. This scaffold has cardiomyocytes cells seeded onto it and is approximately 
15mm by 15mm by 300µm. The design would also need to hold the 1.0-3.0mL of cell culture media (and 
negligible drug solution volume) surrounding the construct. Therefore, the device must be able to hold the 
size of the construct and the surrounding volume of liquid. After testing with the fibrin microthread 
scaffold, the device could be used with similarly-sized scaffolds.  
Flow to and from the 3D tissue construct, or perfusability, is another function of the overall 
device. Depending on the perfusion system, the flow will be specified as either laminar or turbulent. 
Turbulent flow holds a risk of disturbing cell adhesion or alignment, while laminar flow may not mix the 
added solutions throughout the well. Nevertheless, the flow should be controllable and the apparatus 
should be quickly and easily transferable to each well. Each well however does not need to be perfusable 
at the same time because only one well can be imaged at a time. Finally, there should be no backflow of 
the input/output system due to the risk of contaminating substances entering or leaving the experiment.  
The functions and specifications discussed previously are summarized in Table 14. 
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Table 14: Functions and Specifications 
Functions Specifications 
Heating 
 Keep between 34 and 37°C   
 Evenly distributed heat (+/- 1°C)   
 Heat continuously for 3 weeks   
 Automatic control   
 Not detrimental to imaging   
CO2 
 Keep between 4-6%   
 Evenly distributed throughout wells   
 Automatic control  
Humidity  Between 90-100% relative humidity   
Image-able 
  Can be used on a general microscope stage (8" x 5")   
 Materials used under/above wells must be 85% transparent 
 Materials used under/above wells must have a refractive index <1.52  
Holds 3D Constructs 
 Hold a construct that is 15 x 15 x 0.3 mm   
 Holds 1.0 -1.5 mL of media with construct inside   
Perfusable 
 Laminar/turbulent flow   
 No backflow   
 Can be transferred/used for each well   
 Controllable flow  
 
4.3 Conceptual Design Phase 
After determining the functions and specifications of the design (conceptually shown in Figure 
11), the means used to meet each design element were brainstormed. Following brainstorming, pros and 
cons of each conceptualized solution were determined. After analyzing the pros and cons, a design matrix 
was created to rank each idea. By using this ranking, final design ideas were established. 
 
Figure 11: Conceptual Design of Device 
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4.3.1 Brainstormed Design Elements 
The first step in creating the conceptual design was to have each member of the design team 
conceptualize design concepts on their own. The design team met to share ideas and discuss them. Since 
there were many elements to consider, the order in which to analyze them was determined as seen in 
Figure 12. 
 
Figure 12: Brainstorming Flow Chart of Functions 
 First, the source of heat, CO2, and humidity as well as the perfusion system, including how the 
fluid would enter, exit, and be collected, were brainstormed. These were analyzed first because the design 
team wanted to consider all the possible methods in which these elements could be achieved without 
being restricted by a predetermined shape and structure of the device. The means that the design team 
collectively conceived to achieve the function for each of these elements can be seen in Table 15. 
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Table 15: Means Chart for Device Elements 
Element: Heat Source CO2 Source 
Humidity 
Source 
Input 
Mechanism 
Output 
Mechanism 
Means: 
-Heat Lamp 
-Hot Water 
-Hair Dryer 
-Transparent Film 
Heater 
-Copper Tape 
-Nichrome Wire 
-Heated Cables 
-Heated Mat with 
Embedded Wire 
-Fish Tank Heaters 
-Phase Change Material 
- CO2 
Canister 
-Chemical 
Reaction 
-Candle 
-Water basin 
-Wet paper 
Towel 
-Propylene 
Glycol 
Hydrogels 
-Puncturable 
Stopper (IV 
Luer Lock) 
-Syringe 
Filter 
-Tubing Only 
 
-Puncturable 
Stopper (IV 
Luer Lock) 
-Syringe 
Filter 
-Plunger 
-Ball-valve 
 
 
Each of these brainstormed ideas were evaluated for their pros and cons in the following section.  
All ideas were evaluated in a decision matrix and the ideas with the highest scores were further evaluated 
for overall design ideas. 
These overall designs included the number of wells, the layout of the wells, shape of the overall 
device, and sensor location as indicated in box 2 and 3 of Figure 12. Once this was completed, the design 
team could determine what type of control (box 4) would be best based on the sensors that were used and 
based on the conditions that it would need to monitor. The power source (box 5) could then be determined 
based on the type of control that was used. These detailed designs incorporated all necessary elements and 
were evaluated for their pros and cons.  
4.3.2 Evaluation of Design Elements 
 
Heat Sources 
Incorporating a heat lamp into the design of the device would serve as an external heating source. 
Angling a lamp towards the top of the device would allow for fairly uniform heat. However, since the 
lamp would not be directly on top of the well plate because the microscope would be directly above, there 
may be some variation in temperature. Since the heat is directed towards the top of the 6-well plate, a heat 
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lamp would reduce the amount of condensation that would otherwise form, creating a clearer view of the 
cells in culture. This simple method of heating does not directly interfere with the imaging capability of 
the design as it does not obstruct the microscope objective. However, a heat lamp emitting visible light 
could alter fluorescence microscopy results as well as effect cell growth and function (Halevy et al., 1998; 
Karu, 1999). Lastly, a heat lamp connects to a wall outlet, making it difficult to create an automatic 
control system for it to turn on and off. The pros and cons discussed are summarized in Table 16. 
Table 16: Heat Lamp Pros and Cons 
Heat Lamp 
Pros Cons 
 Simple 
 Less condensation due to heating on top 
 No additional material to image through 
 Light may affect cell growth 
 Could not be used for fluorescent imaging 
or dyes 
 Separate element outside of device 
 Difficult to have automated control 
 
Utilizing hot water as a heat source for the device could be a simple and effective method. Water 
could easily be heated on a hot plate and placed into a container that lies within the device, with 
continuous flow. Depending on the design, this method could simultaneously fulfill the design want of 
having a source of humidity. Water also serves as a better heat conductor than air, which would cause the 
wells to heat relatively fast and more uniform. The issue with this heating method is that the water itself 
may be a source of contamination since it would be heated in a non-sterile environment. This method also 
requires the water to be continually heated externally from the device, leading to extra equipment and a 
decrease in user friendliness. The pros and cons discussed are summarized in Table 17. 
Table 17: Hot Water Pros and Cons 
Hot Water 
Pros Cons 
 Simple 
 Could be concurrently used for humidity 
control 
 Better conductivity fluid than air 
 May need to replenish frequently 
 May be a source of contamination 
 Extra heating element outside of device to 
heat water 
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A hair dryer could provide a simple heat source for the design as hair dryers are readily available 
products and directly connect to a wall outlet to produce heated air. The heated air would blow directly on 
top of the device dispersing heat fairly evenly across the top and causing less condensation to form on the 
cover of the device. A container that surrounded the microscope could also be constructed to contain the 
heated air. The issue with this heating method is that it would be difficult to create an automatic control 
because hair dryers connect to a wall outlet. This may require the user to constantly monitor the 
temperature of the device and manually adjust the hair dryer as needed. With a hair dryer being on for 
long periods of time in the lab, it could become an annoyance and potentially a hazard, as they are loud 
and not intended to run very long. The hair dryer would also require extra material because it would have 
to be supported on an external stand at a specific distance away from the device. The pros and cons 
discussed are summarized in Table 18. 
Table 18: Hair Dryer Pros and Cons 
Hair Dryer 
Pros Cons 
 Simple 
 Heated air would disperse well over the 
top 
 Less condensation due to heating on top 
 Loud 
 High electricity usage 
 Not easily controlled 
 Would need separate holding apparatus 
 
A transparent film heater, seen in Figure 13, is a conductive, clear film that has wires along the 
sides. In order to heat the film, these wires are simply connected to a power source at a specific voltage. 
The main advantage of this heating option is that it is transparent, allowing for ideal imaging. This means 
that the heater could be placed under the wells, evenly distributing the heat and resulting in natural 
convection in the media within the wells. The film is rated to be more than 85% transparent at most 
wavelengths in the visible light spectrum as seen in Figure 14. However, an issue with imaging through 
this heater is that they have a lower transmission when exposed to smaller wavelengths. This means the 
heater would have to be tested to ensure it does not alter imaging quality from a microscope. Transparent 
heaters that are more transparent at the lower wavelengths are more expensive, doubling the cost. Another 
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issue with using this product is that it cannot be cut, shaped, or bent as it would break. The size ordered is 
the size that would need to be used in the device and could not be adjusted afterwards. The pros and cons 
discussed are summarized in Table 19. 
Table 19: Transparent Film Heater Pros and Cons 
Transparent Film Heater 
Pros Cons 
 Can be imaged through (higher 
transmittance at certain wavelengths) 
 Can order any size 
 Even heating on base of device 
 Easy to connect to a power source 
 Can't be shaped or bended 
 Imaging with fluorescent light would 
increase cost 
 Cannot be in contact with water 
 
 
Figure 13: Transparent Film Heater 
 
Figure 14: Transmittance of Transparent Film Heater (“Thin Film Devices”, 2014) 
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Copper tape could be wrapped around wells and inputted with a specific voltage to provide 
heating to the sides of the wells. However, the resistivity of copper is very low (1.724 x 10-8 Ω m), so 
there would need to be a high current which could be dangerous to the user (Engineering Toolbox (2), 
2016). An issue with copper tape is that it could not be placed on the bottom of the wells because it is not 
transparent and would affect the devices capability to image through. Also, since copper is electrically 
conductive, it would short out if in contact with any water. The pros and cons discussed are summarized 
in Table 20. 
Table 20: Copper Tape Pros and Cons 
Copper Tape 
Pros Cons 
 Known resistivity 
 Cheap and easy to machine 
 Not transparent (limited to sides or 
device) 
 High amperage required may be 
dangerous 
 Cannot be placed directly in water 
 
Nichrome wire is a small and ductile metal wire with a high resistivity. When a voltage is 
inputted into the wire, it heats up, which could serve as a heat source for the design. It can be easily 
woven around the 6-well plates making it an ideal solution. However, with the resistivity of this material 
being so high, overheating could become an issue as it could possibly melt the other materials of the 
design. High temperatures could also be a danger to the user and inputting the wire with a low voltage 
would make it difficult to heat in a uniform fashion. Similar to the copper tape, it could not be placed 
below any wells because it is not a transparent material. The pros and cons discussed are summarized in 
Table 21. 
Table 21: Nichrome Wire Pros and Cons 
Nichrome Wire 
Pros Cons 
 Easily shaped (ductile) 
 Known resistivity 
 Does not take up a lot of space 
 Could get too hot  
 Difficult to heat full length of wire with 
low voltages 
 Not transparent (limited to sides or 
device) 
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Heated cables are commercial heating element that are commonly wrapped around pipes to keep 
them from freezing in the winter. These cables are insulated and flexible which could be wrapped around 
the wells of the device for heating. They are, however, typically thicker than desired which requires the 
wells to be further apart. These cables are also relatively long, so there might be excess cable outside of 
the device. Again, this option is not transparent thus limiting it to the sides of the device. On top of this, 
standard heating cables connect to a wall outlet making it difficult to create an automatic control system. 
The pros and cons discussed are summarized in Table 22. 
Table 22: Heated Cables Pros and Cons 
Heated Cables 
Pros Cons 
 Insulated 
 Flexible 
 Difficult to have automated control 
 Not transparent 
 Bulky, long and thick 
 
A heated mat with embedded wire would consist of a thermally conductive material, such as an 
epoxy, that could be molded with wire wrapped in it. It could be fabricated in a shape similar to that seen 
in Figure 15 to avoid impeding imaging capabilities. The advantage of this design idea is that it is 
customizable based on the mold that the thermally conductive material is cast into. It is also electrically 
insulated, meaning that it would not short out when in contact with water. Compared to the other 
conductive materials, there would be better heat distribution over the large area of the base of the device. 
The pros and cons discussed are summarized in Table 23. 
Table 23: Heated Mat with Embedded Wire Pros and Cons 
Heated Mat with Embedded Wire 
Pros Cons 
 Customizable 
 Electrically insulated 
 More even heating 
 Not transparent 
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Figure 15: Conceptual Heat Mat Design 
 
A fish tank heater could be immersed in water to provide heating for the device. By having a 
water source, the design already fulfills the want of having a humidity source. This would also lead to a 
more uniform heat source. The issue with this method is that most fish tank heaters only heat water to 
about 34°C, which is at the lower end of the desired range for the device. The heater is relatively large 
compared to other options which would require the 6-well plate to be modified to accommodate the 
heater. Similar to other options, fish tank heaters connect to a wall outlet, making it difficult to create an 
automatic control system. The pros and cons discussed are summarized in Table 24. 
Table 24: Fish Tank Heater Pros and Cons 
Fish Tank Heater 
Pros Cons 
 Simple 
 Water source provides more even heating 
and humidity 
 Does not reach 37°C 
 Difficult to have automated control 
 Relatively large 
 
A phase change material that changes temperature at 37°C could be placed into the device while 
in use. This would allow the user to know, based on the phase, whether the heating element is at 37°C or 
not. The issue with this is that the phase change only last for a few hours and there would be no way to 
automatically control the phase of the material, making this method difficult to use. The pros and cons 
discussed are summarized in Table 25. 
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Table 25: Phase Change Material Pros and Cons 
Phase Change Material 
Pros Cons 
 Reduces temperature variation 
 Only stays at desired temperature for a 
few hours 
 No automated control 
 
CO2 Sources 
Utilizing a CO2 canister in the design could serve as a readily available and reliable gas source. 
Most labs already have gas canisters available and have regulators for these canisters. Having a CO2 
canister connected to the device via a regulator would create a steady flow of pure CO2 gas. This flow can 
be manually regulated to obtain the desired CO2 concentration, however, automating this regulation, with 
the possible use of a pneumatic solenoid valve, is difficult and could become very costly. A CO2 sensor 
could be facilitated in the design and be connected to an LED or microphone that would pose as an 
indicator to warn the user to adjust the gas regulator, providing the desired concentration. Also, gas 
canisters have to be replaced once emptied. The pros and cons discussed are summarized in Table 26. 
Table 26: CO2 Canister Pros and Cons 
CO2 Canister 
Pros Cons 
 Common in laboratories 
 Can be regulated 
 Automated control is complicated 
 Has to be replaced 
 
Certain chemical reactions are known to produce CO2 gas, like the combustion of hydrocarbons, 
reacting a carbonate with an acid, or the thermal decomposition of carbonates. Some of these reactions 
also produce water, which is favorable to have in the design as it would help stabilize the humidity level. 
However, CO2 and water may not be the only byproducts of a reaction, which means that other unwanted 
substances could accumulate over time, and enter the design. This would introduce unwanted substances 
to the cells, providing inaccurate results. Also, utilizing chemical reaction would require buying and using 
specific chemical reagents which could be expensive. It may also impair user friendliness because it 
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would be difficult to know when to add chemicals when the reaction has run to completion. The pros and 
cons discussed are summarized in Table 27. 
Table 27: Chemical Reaction Pros and Cons 
Chemical Reaction 
Pros Cons 
 Some chemical reactions produce water 
as a product for humidity 
 Byproducts could accumulate over time 
 Byproducts could harm cell growth 
 Reagent are used up quickly 
 Difficult to regulate the amount of CO2 if 
device is not completely airtight 
 
When a candle burns, it releases O2. A candle in an airtight container, once all of the oxygen is 
utilized, would stop burning. This means that by lighting a candle in an airtight container, it would burn 
for a small period of time increasing the amount of CO2 in the device and maintaining this level. 
However, because it burns out due to O2 depletion, this means that there would be no O2 supply for the 
cells in the device. Also, if the device is not completely airtight, it may be difficult to predict the 
atmospheric CO2 percentage that is produced. In addition, the candle could be a fire hazard, create smoke, 
and would take up valuable space within the device. The pros and cons discussed are summarized in 
Table 28. 
Table 28: Candle Pros and Cons 
Candle 
Pros Cons 
 Readily available 
 Difficult to regulate the amount of CO2 if 
device is not completely airtight 
 Fire hazard 
 Takes up space 
 Smoke in device 
 Uses up O2 
 
Humidity Sources 
When a source of water is heated, the surrounding area would have a higher percentage of 
humidity, corresponding to the temperature of the water and the surface area being heated. If a water 
basin were incorporated into the design of the 6-well plate, the level of humidity would be increased with 
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respect to the temperature of the system. This method is very simple as it only requires the user to 
occasionally fill the basin with water once it begins to run out. This method also does not interfere with 
the imaging capability and the typical design of the 6-well plate. The main issue with this idea is that the 
water might spill or leak out of the basin and interfere with the cellular and electrical aspects of the 
design. The pros and cons discussed are summarized in Table 29. 
Table 29: Water Basin Pros and Cons 
Water Basin 
Pros Cons 
 Simple to use 
 Holds large amount of water so it would 
last long 
 Easy to know when to refill 
 Could spill and interfere with the 
electrical components of the design 
 Additional element to consider when 
design container 
 
Instead of having an open source of water, a wet paper towel could be placed inside the system to 
create humidity. This method would be very easy to use and would not require any additional changes to 
the original design of a 6-well plate. The risk of water leaking or spilling decreases as well, which would 
be safer to use when taking into account the electrical components of the design. The main issue with this 
method is that paper towels do not retain a large amount of water, so they would have to be rewetted 
frequently. It would also be more difficult to determine when the paper towels would require rewetting 
because there is no clear visual difference between wet and dry paper towels. The pros and cons discussed 
are summarized in Table 30. 
Table 30: Wet Paper Towel Pros and Cons 
Wet Paper Towel 
Pros Cons 
 Simple to use 
 Easy to design around 
 Water would not spill 
 Hard to determine when rewetting is 
needed 
 Doesn’t hold a lot of water 
Propylene glycol is a solution that is commonly mixed with water and used in cigar humidors. It 
is hygroscopic to about 70% relative humidity which means that it maintains a relative humidity level 
under 70%. Also, this method would save space in the design and would prevent leaking as there would 
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be no open source of water. The issue with this method is that the solution is cytotoxic to cells and only 
maintains 70% relative humidity which is significantly lower than what is needed for the design (at least 
90%). The pros and cons discussed are summarized in Table 31. 
Table 31: Propylene Glycol Hydrogels 
Propylene Glycol Hydrogels 
Pros Cons 
 Not an open water source 
 Could save space 
 No leaking 
 Propylene glycol is cytotoxic 
 Maintains approximately only 70% 
relative humidity 
 
Input/Output/Collection Systems 
A puncturable stopper (Figure 16) could be used in a variety of configurations. Figure 17 shows a 
needle connected to tubing that is connected to a syringe inputting liquid into the well and shows a similar 
set up removing liquid. In addition, it shows that these outputs could be placed on the same side of the 
device. If desired, the input and output could be the same location as long as the input was below the 
media line so liquid could be extracted out as well. A puncturable stopper for the input in each well would 
create an easy and effective way to perfuse drugs into each individual well. A small circular opening 
could be made and a puncturable stopper would be placed in this opening. This would prevent cell 
contamination during perfusion as the stopper allows for a syringe needle to puncture through it, but 
would not allow microbes or unwanted substances to enter post-perfusion. The issue with this method is 
that it requires the use of syringe needles which can become a safety risk if not handled appropriately. 
Also, after many uses, the puncturable stoppers could become less reliable as they may experience 
leaking or introduce undesired substances to enter the system. This means that the stoppers would have to 
be replaced after a certain number of uses. The pros and cons discussed are summarized in Table 32. 
Table 32: Puncturable Stopper (IV Luer Lock) Pros and Cons 
Puncturable Stopper (IV Luer Lock) 
Pros Cons 
 Prevents contamination during perfusion 
 Simple to use with a syringe and needle 
 Have to be replaced as needed 
 Might experience leaking if not replaced 
as needed 
 Needles (sharps) required 
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Figure 16: Male IV Luer Lock (Qosina®) 
 
 
Figure 17: Puncturable Stopper Input and Output Designs 
 
Use of a syringe filter (seen in Figure 18) in the design would maintain sterility when introducing 
new solutions to the individual wells of the design. A syringe filter could be connected to tubing that is 
connected to each well. Many configurations are possible, similar to the locations seen in Figure 17. This 
filter would be easy to use as it does not require any needles. The syringe filters, however, are larger than 
the puncturable stoppers, increasing the space required on the microscope stage for the device. These 
filters have to be replaced after a certain number of uses that would be determined through testing. Liquid 
may also collect in the filter resulting in waste of inputted liquid and in possible inaccurate results while 
testing if the waste is not calculated for correctly. The pros and cons discussed are summarized in Table 
33. 
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Table 33: Syringe Filter Pros and Cons 
Syringe Filter 
Pros Cons 
 No sharps required 
 Sterile 
 
 Extra material (makes design bulky) 
 Loss of inputted solution 
 Requires frequent replacement 
 Clotting can occur 
 Greater chance for trapped air bubbles 
 
 
Figure 18: Syringe Filter 
 
Using just tubing to perfuse drugs into the device would be a simple and easy to use solution, 
however, it does not address the problem of sterility. In order to maintain a sterile environment, the tubing 
and perfusion apparatus must always be connected. This may make the device unwieldy with the 
connecting tubes, which would need adapters as well. This design also creates the possibility of backflow 
in the tube if the liquid was moved, which could affect the sterility of the device. The pros and cons 
discussed are summarized in Table 34. 
Table 34: Tubing Only Pros and Cons 
Tubing Only 
Pros Cons 
 No sharps required 
 
 In order to stay sterile, tubing and syringe 
must be attached 
 Extra material (makes design bulky) 
 Tubing adapters necessary 
 Possibility of backflow 
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The ball-valve outlet design (seen in Figure 19) involves an outlet tube that releases the wells 
contents by turning a ball-valve mechanism. Closed, the ball obstructs any liquid from exiting the well, 
but when turned, the ball reveals the drain tube which then collects at a larger collecting tube. The turning 
motion of the shaft handle is user friendly and the contents could be drained in one turn from either the 
side or bottom of the well. However, the design has many flaws including that if one well was drained, 
the others could obstruct it from fully draining. The extra material for the shaft and valve would take up 
more space and be difficult to clean since it is difficult to disassemble. Because of the manual nature of 
the drainage it would be difficult to seal the ball valve to obstruct liquid, which is a sterility issue. It 
would also be difficult to output an exact amount because there is no way to measure how much liquid 
was drained. The pros and cons discussed are summarized in Table 35. 
Table 35: Ball-Valve Pros and Cons 
Ball-Valve 
Pros Cons 
 Regulated removal of unwanted liquids 
 Easy to use 
 Difficult to clean 
 Extra material (makes design bulky) 
 Manual output 
 Not easily sealed to well, not fully sterile 
 
  
Figure 19: Ball Valve Design 
 
The plunger output design is similar to the ball valve design except it utilizes syringe plungers. 
The stoppers of the syringes are sealed to a hole in the side of the well, and the plunger is pulled out so 
that the stoppers release the contents of the well as shown in Figure 20. The contents are channeled into a 
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shared channel, similar to the ball-valve idea in Figure 19. The pieces would be more easily removed than 
the ball-valve and could be made from existing syringes to ensure a good suction seal. The downsides to 
this design is that the manual plungers may be accidentally moved open and there would be extra material 
connected to the device. The pros and cons discussed are summarized in Table 36. 
Table 36: Plunger Pros and Cons 
Plunger 
Pros Cons 
 Pieces can be separated for cleaning 
 Easy to use 
 Easier to make from existing syringe 
plungers 
 Plunger can be sealed to well 
 Manual output 
 Extra material (makes design bulky) 
 Plungers could be accidentally moved and 
opened 
 
  
Figure 20: Plunger Design 
4.3.3 Quantitative Assessment of Design Elements 
A decision matrix was utilized to rank design element ideas by how well they achieved each 
objective. This decision matrix was completed to determine which elements would be further explored in 
overall design of the device discussed in the following section. A rating from 1 to 5 was created for each 
objective. The rubric containing these ratings can be found in Appendix F.  
The decision matrix, seen in Table 37, analyzed each design element that was brainstormed in 
four categories: heat source, CO2 source, humidity source, and perfusion system. Both constraints (C) and 
objectives (O) were assessed. The elements in each category were first analyzed based on if they met the 
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constraints. A Y (Yes) or N (No) was given to each element if they met or did not meet a constraint. If a 
design element did not satisfy a constraint, it was not further analyzed. 
Table 37: Decision Matrix Example 
 
For elements that did meet all constraints, objectives and corresponding sub-objectives were then 
analyzed. Only objectives relevant to the design element category were analyzed. For example, for heat 
source, temperature regulation was analyzed, but CO2 regulation was not. Using the rubric previously 
discussed, a score of 1 to 5 was given to each element. This score was then normalized by dividing the 
score by the largest score received by any element for that specific sub-objective. The scores for all sub-
objectives under each main objective were added together. This was then multiplied by the main 
objective's weight based on the objective's importance. The weighting for each main objective was 
determined based on the PCC completed in Chapter 3. Scores that each objective received in the PCC 
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were calculated to be out of 100% and this was then the weight percent used in the decision matrix. 
Finally, the scores for each objective under each element were added to obtain a final score.  
The final scores for each of the four design element categories assessed can be seen in Table 38. 
Completed design matrices that resulted in these scores can be seen in Appendix G.  The highest rated 
elements, highlighted in yellow, were incorporated into overall designs discussed in the next section.  
Table 38: Decision Matrix Results Summary 
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5. Development and Verification of the Final Design 
Following quantitative analysis, the design team received approval of the top elements from the 
clients and users. Based on this, the design team decided to move forward with overall device designs that 
incorporated either the transparent heater or the heat mat with embedded wire for the heat source and 
either a puncturable stopper or syringe filter for perfusion. The option for CO2 source was limited to a 
CO2 canister, and the option for water was narrowed down to use of a water basin. The following sections 
analyze preliminary overall design ideas that incorporate these elements. The goal of analysis was to 
understand how individual elements could fit together in an overall design. This helped to ensure that the 
individual elements that scored the highest would be able to be incorporated into an overall design in 
conjunction with the other elements. Components of these preliminary overall design ideas were tested in 
feasibility studies. Following completion of feasibility studies, a final design was created.  
5.1 Designs with Modified 6-Well Plate Bases 
The first set of preliminary overall designs were designs that modified the base and cover of a 6-
well plate. In general, these designs consist of perfusion from the side of the device and have two tubes 
coming out from the side of each well. Each tube could be connected to a syringe filter or puncturable 
stopper for sterility. Since there are two separate tubes, one could be used for input and a separate one for 
output. The heating element for all designs is at the bottom. The cover(s) in each design has a hole for 
sensors to be placed through and into one of the wells. Sensors could be connected to an Arduino for 
control of temperature and CO2. The covers would also have a hole for tubing that would provide a source 
of CO2. 
The issue with this type of design is that a standard 6-well plate cannot be used. For each use, the 
6-well plate would need to be sterilized beforehand. Three design concepts that consist of a modified 6-
well plate were made seen in Table 39. These designs all show the transparent heater as the heat source, 
however, a rubber heat mat could also be used below the 6-well plate in each of the design. The 
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descriptions in Table 39 do not consist of the previously described, general characteristics that are similar 
to all three designs. Instead, only the differences are described.  
Table 39: Modified 6-Well Base Designs 
Model of Design Description 
 
Design 1  
This design has 3 main components: a 
modified 6-well plate, modified 6-well 
cover and heating element (transparent 
heater shown). The advantage of this 
design is that there are not many parts. 
 
Design 2 
This design is similar to design 1, 
however, it has an additional cover. The 
advantage of this is that the additional 
cover creates more area to contain, prevent 
loss of, and control heat, CO2, and 
humidity.  
 
Design 3  
This design is similar to design 2, 
however, instead of just another cover, it 
has a full box encasing the modified 6-well 
plate. The advantage of this design is that 
water could fill the bottom of the box to 
have a larger surface area for humidity. 
The disadvantage is that additional 
material on the bottom would have to be 
thin and clear so the device can still be 
imaged with the limited working distance 
of the microscope. 
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5.2 Designs with Modified 6-Well Plate Covers Only 
The second set of preliminary overall designs were designs that consisted of a modified cover of a 
6-well plate but not the base. In general, these designs consist of perfusion from the top of the device and 
only have one tube extending from the top. The tube could be connected to a syringe filter or puncturable 
stopper for sterility. By extending the tubing to the bottom of the well, the same tube could be used for 
input and output. The heating element for both designs is at the bottom. The modified cover in each 
design has a hole for sensors to be placed through and into one of the wells. Sensors could be connected 
to an Arduino for control of temperature and CO2. The covers would also have a hole for tubing that 
would provide a source of CO2. The space between the 6-wells in the plate can be filled with water for 
humidity with additional tubing through the cover.  
The advantage of this type of design is that a standard 6-well plate can be used. For each use, 
only the cover of the 6-well plate would need to be sterilized beforehand. An already used 6-well plate 
can be discarded, and a new one can be used. This reusability prevents functionality damage from 
repeatedly sterilizing the polystyrene of a 6-well plate. Two design concepts that consist of a modified 6-
well plate cover were made seen in Table 40. These designs both show the transparent heater as the heat 
source, however, a rubber heat mat could also be used below the 6-well plate in each of the designs. 
These designs also show puncturable stoppers, however, syringe filters could be used instead. The 
descriptions in Table 40 do not consist of the previously described, general characteristics that are similar 
to both designs. Instead, only the differences are described.  
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Table 40: Modified 6-Well Cover Designs 
Model of Design Description 
 
Design 1  
This design consists of flexible tubing 
that is fed through a rigid tube on the 
top of the cover. The advantage of this 
design is that the tubing could be 
collected in a manifold for ease of use.  
 
 
Design 2  
This design consists of rigid tubing that 
goes through the top of the cover. The 
advantage of this design is that it does 
not take up as much room compared to 
using a manifold as seen in design 1.  
 
 
Design 3 
This design is larger than design 1 and 
2, but keeps everything together as one 
unit.  
 
5.3 Preliminary Testing of Overall Design Ideas 
Preliminary testing was conducted in order to determine how well each aspect of the overall 
design ideas would perform. Control system, temperature, imaging, humidity, CO2, and perfusion testing 
was performed. Various components of the device were constructed in order to execute these tests.  
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5.3.1 Control System  
Control system testing was important to ensure that the proposed configuration would function as 
expected. It was also necessary to determine what sensors could be used in the device.  
The proposed control system for the device to maintain the temperature and CO2 levels within the 
specified ranges is shown in Figure 21. Sensors connected to the device communicate with an Arduino 
indicating if temperature or CO2 levels are too high or too low. For temperature, the heating element is 
connected to a power source and to a relay. The relay turns the voltage supply to the heating element on 
or off based on the reading from the temperature sensor.  
A similar concept is designed for CO2 regulation. A CO2 canister with a regulator attached would 
be set to a specific psi and tubing from the regulator would be connected to a solenoid valve. The solenoid 
valve is connected to a power supply and relay. Based on the CO2 sensor reading, the voltage to the 
solenoid turns on or off. Supplying voltage to the solenoid opens the valve letting gas pass through to the 
device. Removing voltage supply closes the valve and stops CO2 flow to the device. 
 
Figure 21: Device Control System 
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To ensure that this control system would function, a temperature sensor and a CO2 sensor had to 
be chosen. The temperature sensor tested for the control system was an epoxy coated Negative 
Temperature Changing resistor (NTC thermistor) shown in Figure 22. To determine the relationship 
between the resistance that the thermistor produces and the corresponding temperature, the produced 
resistance was recorded at different temperatures ranging from 0-50°C. The resistor was taped to a 
mercury thermometer and heated in a cup of water from 0°C to 50°C. The resistance-temperature 
readings were recorded as the temperature changed. The resulting temperature/resistance relationship is 
shown in Figure 23. The equation of the non-linear line, with an R-squared value of .9993 was recorded 
as: 
𝑦 = 0.0001𝑥4 − 0.011𝑥3 + 0.4061𝑥2 − 7.6796𝑥 + 71.987 
 
Figure 22: NTC Epoxy-Coated Thermistor 
 
Figure 23: Thermistor Calibration 
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To read the resistance of the thermistor, a voltage divider could be used. The power supply, V1, is 
connected to two resistors in parallel. The first resistor is the thermistor, and its resistance changes with 
respect to the temperature. Since it is expected that the temperature range encountered is between 30-
40°C, the resistance value of R1 is a corresponding resistance at 34°C (in between 30 and 40°C). This 
value is estimated to be 6.3kΩ, using the curve shown in Figure 23. The voltage connected in between the 
two resistors would be sent as an analog input to the Arduino, A1. 
 
Figure 24: Voltage Divider 
A change in temperature causes a change in the voltage outputted from the voltage divider (see 
Figure 24). The equation used to measure the value of Rt is: 
𝑅𝑡 =  (𝑅1 ∗ 𝑉1/𝑉𝑜𝑢𝑡) − 𝑅1 
which allows the Arduino to calculate the given resistance of the thermistor. From this, the equation 
obtained allows the Arduino to identify the corresponding temperature at the measured resistance. If this 
temperature value is above or below the threshold temperature values, 34-37°C, the Arduino outputs a "0" 
or a "1" respectively. This digital output is then inputted into a relay which regulates the temperature of 
the heater.  The circuitry for this can be found in the User Manual in Appendix S.  
In order to continuously read the CO2 within the device, a 100,000ppm MH-Z16 NDIR CO2 
sensor was tested. This sensor is equipped with an I2C/UART board which communicates with the 
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Arduino. In order to calibrate the sensor, it was placed in an incubator and the CO2 levels were set to 0%, 
2.1%, 4%, and 5%. The resulting ppm readings were then plotted to create a calibration curve shown in 
Figure 25. This curve was used in the Arduino code to output the reading of the level of CO2 in ppm. This 
code was later tested in the device with a CO2 gas input.   
 
Figure 25: Calibration Curve of the CO2 Sensor 
5.3.2 Temperature 
Two heat source elements to regulate the temperature of the device were tested: the heat meat 
with embedded wire and the transparent film heater.  
Heat Mat 
The heat mat idea consists of nichrome wire that was embedded within a thermally conductive 
epoxy. The nichrome wire would be connected to a voltage source to heat up. The heat would then be 
dispersed throughout the epoxy. To fabricate the heat mat, a mold could be produced, as seen in Figure 
26. The mold would result in a cast that would be slightly smaller than the space on the underside of a 6-
well plate. This way, the cast produced could be easily placed into and out of a 6-well plate. The mold 
would not have a bottom so that the cast could be removed easier. In order to contain the epoxy before it 
hardens, aluminum foil could be used as a bottom base. The nichrome wire would be weaved into the 
mold. The epoxy could be then be poured on top and set in place.  
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Figure 26: Mold Model 
 A proof of concept for the heat mat was constructed. The proof of concept consisted of nichrome 
wire weaved around the wells of a 6-well plate that was fixed in place with aluminum tape. Before testing 
this, the nichrome wire alone, without any aluminum tape, was tested.  
To set up the experiment with nichrome wire alone, wire was wrapped around the wells and taped 
in place. For each well, 3 mL of room temperature water was added. The two ends of the wire were 
connected to a 2V power source. The required voltage to heat up the nichrome wire to 39°C was 
calculated for the 2 foot length that was used (See Appendix H). The voltage required at 39°C was 
calculated because the nichrome wire would most likely need to be hotter than 37°C because there would 
likely be a temperature difference between the nichrome wire and the resulting temperature of the water.  
It was found that only 0.909V was needed. However, when the nichrome wire was attached to 0.909V, it 
did not heat up more than one degree in 20 minutes. This is likely due to the fact that nichrome has a very 
high resistance (2.0836 Ω/m) and is typically not used with such low voltages. When the nichrome wire 
was connected to the 2V source, the temperature of the water was recorded over time. After 15 minutes, 
the water barely reached 25°C.  
In order to provide more contact to the wells, the nichrome wire was wrapped in aluminum tape. 
The set up for this experiment can be seen in Figure 27. The aluminum foil wrapped nichrome wire was 
held in place to the bottom the 6-well plate with electrical tape. Again, 3 mL of water was added to each 
well. As seen in Figure 28, the water heated up much quicker when given the same 2V source compared 
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to the heat-up profile of water when the wire alone was used. Once the water reached 37°, the voltage was 
lowered in order to determine if lowering the voltage would lower the overall temperature of the water 
keeping it between 34 and 37°. As seen in Figure 28, lowering the voltage did help keep the water in the 
desired temperature range. One observation from this experiment that is important to note is that the 
temperature of the nichrome wire itself when wrapped in the aluminum foil reached a high of 80°C.  
  
Figure 27: Nichrome in Aluminum Tape Testing 
 
Figure 28: Nichrome Wire Results 
Transparent Heater 
Next, the transparent film heater was tested. The design team receive two samples from Thin 
Film Devices. Each sample was the same size measuring 14.6 cm by 11.1 cm. The two samples were both 
0.7 mm thick and had a 1450 ± 100Å thick Indium Tin Oxide (ITO) coating on one side of the glass. The 
66 
 
resistance was measured to be approximately 15 Ohms.  A data sheet for the transparent heater can be 
found in the User Manual in Appendix S. 
In order to determine the optimal voltage needed to power the transparent heater a calculation 
was completed in Appendix I.  To experimentally test this time, one transparent heater was placed under a 
6-well plate that was filled with 3 mL of room temperature water in each well. The heater was connected 
to a 14.5V DC source and a 12V DC source in two different experiments. As a control, the experiments 
were conducted in the same room. The temperature of the heater and the water for both voltage values 
was recorded over time using a metal probe and can be seen in Figures 29 and 30. The water in the 14.5V 
experiment heated to 37°C in 22 minutes, whereas, the water in the 12V experiment reached 37°C in 28 
minutes. Because the change in time to heat up was not significant, it was decided that 12V DC would be 
used for all future experiment with the transparent heater because it is a more conventional voltage value.  
 
Figure 29: Temperature of Water and Transparent Heater at 14.5V over Time 
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Figure 30: Temperature of Water and Transparent Heater at 12V over Time 
The next experiment was conducted to ensure that both of the heaters were the same resistance. 
The transparent heaters were again placed under a 6-well plate filled with 3 mL of water in each well. 
Temperature of the water and heater were recorded every two minutes over time. The two transparent 
heaters heated up in a similar fashion. The differences in the heat-up profile may be due to the placement 
of the temperature probe. For one film, the probe was placed closer to the voltage input than the other 
which could have been the cause of the difference. This issue of even heating of the transparent heater is 
discussed in more detail later in this section. The results can be seen in Figure 31. 
 
Figure 31: Transparent Heater Heat-Up Profile 
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The goal of the next experiment was to ensure that turning on and off the voltage supply resulted 
in a corresponding change in the temperature of the heater. From this, ramp-up and ramp-down times 
could be determined. Using the same experimental set-up as the previously described experiments, the 
transparent heater was supplied with 12V and 3 mL of water in each well was heated to 37°C. Once the 
water temperature reached 37°C, the voltage power supply was turned off. When the water dropped 
below 34°C, the power supply was turned back on. Two cycles of this manual control of the voltage and 
the resulting water temperature is shown in Figure 32. It was determined that the ramp down time 
between 37 and 34°C averages 9 minutes. The ramp-up time averages 7 minutes.  
 
Figure 32: Manual Control of Transparent Heater Results 
Another feasibility test that was conducted for the transparent heater was temperature 
distribution. Both transparent heater samples were imaged. Three trails total were conducted. The first 
two trials were with Heater 1 and the third trial was with Heater 2. In the first and third trial, a 6-well 
plate was centered on the transparent heater that was connected to a 12V DC power source. In the second 
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trial, the 6-well plate was turned 90° and moved closer to the end of the transparent heater with the leads 
connecting to the 12V DC power supply. Various conditions were imaged. The image was taken ten 
minutes after each condition was set up. Table 41 summarizes the conditions that were imaged, the 
temperature range that was seen, and the magnitude of the temperature range. Table 42 describes where 
the temperature range for each condition was evaluated. Table 43 shows the images taken for each trial 
and each condition. Images shown in Table 43 extend to the bounds of the transparent heater.  
Table 41: Temperature Range Results for Each Condition 
Condition Description Heater 1 (Trial 1) Heater 1 (Trial 2) Heater 2 (Trial 3) 
 Temp. 
Range    
(°C) 
 
Magnitude 
of Temp. 
Range 
(°C) 
Temp. 
Range    
(°C) 
Magnitude 
of Temp. 
Range 
(°C) 
Temp. 
Range 
(°C) 
Magnitude 
of Temp. 
Range 
(°C) 
A) Transparent Heater Only 
33.5-
50.6 
17.1 
32.5-
43.3 
10.8 
38 – 
44.8 
6.8 
B) Transparent Heater with 
6-Well Plate, Covered 
Not Imaged 
29.8-
33.3 
3.5 
29.8 - 
34.6 
4.8 
C) Transparent Heater with 
6-Well Plate, Uncovered 
34.5-
46.1 
11.6 
37.3-
44.5 
7.2 
38.2 - 
43.4 
5.2 
D) Transparent Heater with 
6-Well Plate and 3 mL of 
water in wells, Covered 
Not Imaged 
31.6-
34.9 
3.3 
30.4-
35.4 
5 
E) Transparent Heater with 
6-Well Plate and 3 mL of 
water in wells, Uncovered 
31.5-
38.4 
6.9 
35.1-
38.3 
3.2 
34.9-
39.3 
5.3 
F) Transparent Heater with 
6-Well Plate, 3 mL of water in 
wells, 5 mL of water in 
humidity basins, Covered 
26.4-
31.3 
4.9 
31.4-
34.7 
3.3 
30.3-
35.2 
4.9 
G) Transparent Heater with 
6-Well Plate, 3 mL of water in 
wells, 5 mL of water in 
humidity basins, Uncovered 
30.5-
35.5 
5 
35.1-
38.3 
3.2 
35.3-
39 
3.7 
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Table 42: Description of Temperature Range Evaluated for Each Condition 
Condition Description 
Description of Temperature Range 
Evaluated 
A) Transparent Heater Only Entire transparent heater surface 
B) Transparent Heater with 6-Well Plate, Covered Entire 6-well plate cover surface 
C) Transparent Heater with 6-Well Plate, Uncovered Surface within the wells of the 6-well 
plate only 
D) Transparent Heater with 6-Well Plate and 3 mL of 
water in wells, Covered 
Entire 6-well plate cover surface 
E) Transparent Heater with 6-Well Plate and 3 mL of 
water in wells, Uncovered 
Surface within the wells of the 6-well 
plate only 
F) Transparent Heater with 6-Well Plate, 3 mL of 
water in wells, 5 mL of water in humidity basins, 
Covered 
Entire 6-well plate cover surface 
G) Transparent Heater with 6-Well Plate, 3 mL of 
water in wells, 5 mL of water in humidity basins, 
Uncovered 
Surface within the wells of the 6-well 
plate only 
 
Table 43: Thermal Camera Results (Electrical leads were on the left of each image) Warmer colors, such as red and white, 
indicate hotter areas and cooler colors, such as purple and black, indicate cooler colors 
 Heater 1 (Trial 1) Heater 1 (Trial 2) Heater 2 (Trial 3) 
A 
   
B (No data) 
 
  
C 
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D (No data) 
 
  
E 
   
F 
   
G 
   
 
 
Based on the preliminary temperature testing results, it was determined that the transparent heater 
would function better than nichrome wire embedded in thermally conductive epoxy. Although the thermal 
camera testing indicated a larger range across the device than desired, it must be noted that the thermal 
camera is influenced by the angle of the camera, and if not directly parallel with the transparent heater, 
results could be inconsistent. Therefore, more testing with the transparent heater. This testing included the 
proposed design for a 3D printed holder for the device discussed further in Section 5.4.  
72 
 
In order to further explore the heat variation, potential thermistor placement, and Arduino coding, 
an hour and a half temperature test was conducted using 7 temperature probes rather than just one in 
previous experiments. For experimental set-up, the 6-well plate was placed in the holder with the 
transparent heater underneath. A testing cover was created with 7 holes in it. The holes allowed for 
temperature probes to be placed into each of the 6 wells and into one of the humidity wells. Each well 
was labeled 1-7, with 7 being the humidity well. Each well contained 3mL of water and the two humidity 
basins each contained 1.5mL of water. With this setup, as shown in Figure 33, readings were taken using 
the Arduino. It also must be noted that 12V AC was used rather than 12V DC because the manufacturers 
of the transparent heater suggested that AC may heat more evenly.  
 
Figure 33: Temperature probe experiment setup 
 
This experiment was repeated 4 times with different variables. All results are shown in Appendix 
J. The first experiment consisted of a thermistor placed in well 7 (the humidity basin) with the Arduino 
controlling the heater between the temperature range 35-35.5℃. The results showed that well 2 had the 
highest temperature. After the experiment was conducted, it was noted that the thermistor was slightly 
broken at the tip and therefore was not reliable. 
Due to these results, a new thermistor was calibrated and used in the next experiment. The 
thermistor was placed in well 2, the hottest recorded well. The temperature range of the Arduino was 
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changed to 36-36.5℃ to better keep all wells in the desired range. The results showed well 1 was 
recorded to have the highest temperature and that the thermistor was not reading the same values as the 
probe placed in that well. Because of this, this the thermistor was recalibrated and the experiment was 
repeated. 
The third experiment used the updated calibration equation for the thermistor and the thermistor 
was placed in well 1. The results showed that the thermistor was still slightly off and that the hottest well 
was once again well 2. This led to the final temperature probe experiment. The fourth experiment used an 
altered calibration curve for the thermistor that was placed once again in well 2. After these four 
experiments, it was determined that miss-calibration of the temperature probes may have been the cause 
of variation between wells.  
 The test was repeated once more with calibrated probes. To calibrate, all probes were placed in 
ice water. A mercury thermometer was used to confirm the temperature was 0℃. The temperature offset 
for each probe was recorded. Using the calibrated probes, the thermistor was placed in well 2. The results, 
seen in Figure 34, show that the temperature distribution was smaller than before. The difference between 
the maximum and minimum temperature throughout the entire experiment was 2.2℃ or less. 
 
Figure 34: Temperature probe experiment with calibrated probes. 
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5.3.4 Humidity  
After exploring the features of different brands of 6-well plates, it was found that Falcon 
Corning® 6-well plates have two inner holes in between the wells as shown in Figure 38. Tubing can 
enter into one of these basins through a tube entering through the cover of the 6-well plate. These two 
holes are connected to each other but not to any other area of the 6-well plate. The purpose of these holes 
are for manufacturing purposes and do not have an effect on the individual wells (Falcon Corning® 
Technical Representative, Personal Communication, November 21, 2016). This is ideal because it could 
serve as a water basin to maintain humidity levels of the design.  
 
Figure 35: Humidity Basin with Tubing 
A humidity sensor was used to test the relative humidity level when water was added to the 6-
well plate in different locations. The sensor was connected to the Logger Pro® Vernier software which 
allows for real time analysis. The humidity in the ambient air was measured to be 18%.  For testing 
purposes, holes were made in cover of the 6-well plate. Four different liquid distributions were tested: an 
empty 6-well plate, a plate with 3 mL of media in each well, a plate with just 5 mL of water in the 
humidity basins, and one plate with both 3 mL of media in each well and 5 mL of water in each humidity 
basin. These configurations can be seen in Figure 39.  For testing of each configuration, the transparent 
heater was kept at 37°C and the water and media added was also at 37°C. After five minutes, three 
measurements per configuration were recorded: one in the left well, one in the middle well, and one in the 
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right well. The sensor was fixed inside a well by the apparatus shown in Figure 40. Tape was used to 
block air flow in the holes in the cover that were not in use. Using Logger Pro®, the percentage of 
relative humidity was measured for 60 seconds and the "average" function was used to calculate the 
average humidity. 
 
Figure 36: Humidity Experiment Setup 
 
Figure 37: Humidity Testing Setup 
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The results of this experiment are shown in Table 45. The empty 6-well resulted in the lowest 
relative humidity, and the 6-well with both water and media resulted in highest relative humidity reading. 
Also, the 6-well with just water in the humidity basins reached a relative humidity of 90% in two of the 
three wells measured. The left well had the lowest relative humidity of the three wells at 88% which was 
most likely due to the uneven distribution of heat across the transparent heater discussed previously. 
Despite this outlier, the experimental group with only water demonstrates that adding water to the 
humidity basins does contribute to the humidity within the entire device. 
Table 44: Humidity Data 
 
 
5.3.3 Imaging 
Another important consideration for the transparent heater was how well it could be imaged 
through under fluorescent microscopy. In order to test this, the Leica fluorescent microscope was used to 
image pre-made fluorescently-stained samples. The samples that were used, from Katrina Hansen in 
Gaudette Lab, were rat cardiomyocyte-seeded fibrin thread and gel constructs made via Chrobak et al. 
protocol. They were immunostained for Nuclei (blue), Connexin 43 (green), and Alpha Actinin (red). A 
group of cells on a thread were focused on by the microscope, and two pictures were taken: a control with 
the samples in the 6-well, and an experimental with the transparent heater underneath. These images were 
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replicated in all three major color channels (red, green and blue). Images were captured at both 10x and 
20x magnification as well of the cell groups of interest. The results can be seen in Figures 35 and 36. 
 
Figure 38: Threads seeded with cardiomyocytes at 10x magnification. Images were taken in the blue, green, and red channels in 
a control in the 6-well (a, c, and e), and with the transparent heater underneath (b, d, and f). 
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Figure 39: Threads seeded with cardiomyocytes at 20x magnification. Images were taken in the blue, green, and red channels in 
a control in the 6-well (a, c, and e), and with the transparent heater underneath (b, d, and f). 
 
To quantify the fluorescence, ImageJ was used to measure the fluorescence at the brightest point 
for each image. After uploading each picture, the "Split Channels" function separated the blue, green, and 
red channels for each image. This allows for analysis of the fluorescence that, for example, shows only 
the green fluorescence in grayscale if the image was taken using the green channel on the microscope. In 
the respective channel, the same brightest region was selected in each respective image. The average, 
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minimum, and maximum fluorescence were measured. An example of a selected region can be seen in 
Figure 37. 
 
Figure 40: Image of Blue channel, without heating film at 10x magnification. The selection of the area of interest can be seen as 
the yellow box on the brightest spot. 
The resulting findings of the area of selection, mean, minimum, and maximum fluorescence 
values in the red, green, and blue channel at the two magnifications are shown in Table 44.   
Table 45: Data of Fluorescence comparison with and without the transparent heated film at 10x and 20x magnification.  
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From analysis, there was no significant difference (p>0.01) between the control and experimental 
fluorescent values for maximum, median, and mean fluorescence as determined by statistical T-Test. 
Furthermore, the maximum fluorescence values for both groups are similar distances from the mean 
value, indicating comparable intensity. These similarities indicate that there was no loss in brightness or 
fluorescence using the transparent heater under a conventional 6-well plate 
An additional experiment was performed to determine if the changes in fluorescence were due to 
the transparent heater or due to continuous bleaching of the dyes. The sensitive fluorescent dyes that were 
used on the sample become "bleached" over time and lose fluorescence as they are exposed to the lights 
of the microscope. The pre-made samples had already been imaged before, so the images were already 
less fluorescent than when they were first imaged. Two sets of images were taken at 20x magnification, 
switching which variable was tested first. Results showed that the transparent heater does not affect the 
amount of fluorescence detected and any change may be due to bleaching. The additional 20x 
magnification data can be seen in Appendix K. 
Pictures using the fluorescent microscope were attempted at 40x magnification. Due to the 
thickness of the transparent heater, the working distance of the microscope would not allow for proper 
focus on the cells at this magnification. The client, Katrina Hansen, indicated that imaging at 40x was not 
crucial to the success of the device.  
5.3.5 CO2 
In order to continuously supply the device with the desired amount of CO2, a gas tank and 
regulator, from the Fluval Pressurized CO2 kit designed for fish tanks, were used. The kit includes a small 
gas tank, containing 20g of CO2, and a small regulator shown in Figure 41. This regulator was connected 
to the system through tubing and a solenoid was incorporated to control gas flow as shown in Figure 42. 
A plastic NPT pneumatic pipe fitting was used to connect the tubing to the solenoid and the solenoid to 
the device as shown also shown in Figure 42.   
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Figure 41: Fluval CO2 Gas Tank and Regulator 
 
Figure 42: NPT Pneumatic pipe fitting (left) and Solenoid Valve (right) 
 The copper pipe fittings fixtures shown in Figure 43, were obtained in attempts to stop the 
leakage. Nylon tape was wrapped around the threads as well to create a tighter seal. Despite these efforts, 
the solenoid was still leaking gas. It was determined that the pressure coming out of the CO2 tank was too 
high for the solenoid which caused the leakage. Calculation for the pressure in the tank can be seen in 
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Appendix L. Based on these calculations, the gas tank was outputting a pressure of approximately 5000 
psi and the solenoid only works for up to 120 psi.  
 
Figure 43: Copper pipe fitting fixtures, using Nylon threading tape on threads on right 
Despite the leakage, tests were conducted to ensure that CO2 regulation was feasible if a different 
tank and regulator were obtained. The CO2 tank (half-full), regulator, solenoid, and sensor were 
connected to the device holder as shown in Figure 44. The solenoid was connected to the Arduino and a 
power source. A Vernier CO2 sensor was also placed in the device. This was a control for the experiment 
so the readings from the two sensors could be compared. The regulator valve was manually opened when 
it was known that the code would signal the solenoid valve to open. The readings from the Vernier sensor 
and the sensor connected to the Arduino were recorded over time. The results shown in Figure 45 show 
that the Arduino code and CO2 sensor are functioning as expected. Both sensors detect the presence of 
CO2 in a similar pattern. The Vernier sensor was not calibrated correctly to start which is the cause of the 
offset between the two sensor reading curves. Regardless, this test proved that the plan for the CO2 
system would be viable with the correct CO2 tank and regulator.  
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Figure 44: Initial CO2 system setup 
 
 
Figure 45: Device CO2 sensor and Vernier sensor readings over time (Vernier not calibrated) 
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5.3.6 Perfusion 
 
In order to determine a means for sterile injection of drugs and media, two options for perfusion 
sterility components were explored: the syringe filter and the puncturable stopper. Both of these 
components were tested as seen in Figure 45. The puncturable stopper was punctured more than 20 times 
and each time, there was no backflow or leakage. When the syringe filter was used, there was collection 
of liquid. Although both components suited the needs of the design, the puncturable stopper was easier to 
use, wasted less liquid, and was smaller. For these reasons, the puncturable stopper was further explored. 
Various configurations were explored with the puncturable stopper to determine the configuration that 
resulted in the best diffusion.  
 
Figure 46: Puncturable Stopper and Syringe Filter  
Another design consideration was the orientation of the tubing into the well: from the top or from 
the side. As seen in Figure 47, the stream of dye with perfusion from the side did not diffuse well. The 
dye from the side travelled straight across the well until reaching the opposite side of the well.  Also, 
perfusion from the side would need to modify the 6-well plate base, so the design team decided to move 
forward with tubing going into each well from the top.  
 
Figure 47: Perfusion from side of well at t=2, 5, 10, 30, and 90 seconds. 
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Once it was determined that a puncturable stopper and perfusion from the top would be used, the 
diffusion experiment was set up. For the puncturable stopper, Qosina Male Luer Lock Injection Site 
connectors (part number: 80149) made of ABS and polyisoprene were used because they are designed to 
fit onto existing tubing with luer lock connections. To connect to the luer locks two types of tubing were 
tested, both of which were polyethylene Intramedic® tubing. The first tubing was referred to as "small 
inner diameter tubing" or "smaller tubing" (inner diameter: 0.86 mm, outer diameter: 1.27 mm), and the 
second was referred to as "larger inner diameter tubing" or "larger tubing" (inner diameter: 1.67 mm, 
outer diameter: 2.42 mm). Figure 48 shows the connections for both sizes of tubing with the luer locks. 
 
Figure 48: Assembly of tubing and luer lock for small and large inner diameter tubing. a) Smaller tubing set-up: (1) the tubing, 
(2) tubing luer lock connector (3) female luer lock connector, and (4) the injectable male luer lock. b) Fully assembled smaller 
tubing connector. c) Larger tubing set-up: (1) the tubing, (2) female luer lock connector, and (3) the injectable male luer lock and 
d) fully assembled larger tubing connector 
To assess the perfusion patterns into a liquid-filled well for each assembly, a 6-well plate was 
used and one well was filled with 3 mL of water at 37°C. In a separate container, red food coloring was 
mixed with 37°C water. This colored water would be used to represent a drug and/or media that would be 
perfused into the well. The goal of the dye perfusion experiment was to determine which of the conditions 
created the most distributed mixing of the dye when injected. A fully diffused well can be seen in Figure 
49. For each experimental condition, outlined in Table 46, 1 mL of the dyed water was injected. The 
results are shown in Table 47 with images at different time points. 
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Figure 49: Goal of perfusion profile of dye as soon as possible after injection. 
Table 46: Perfusion Experimental Variables 
Tubing size Tubing Angle Volumetric Flow Rate 
Smaller tubing (0.86 inner 
diameter) 
Vertical (90°) from well bottom 0.2 mL/s (1 mL in 5 seconds) 
Larger tubing (1.67 inner 
diameter) 
Angled (45°) from well bottom 0.1 mL/s (1 mL in 10 seconds) 
 
Table 47: Perfusion Results 
2 Seconds 5 Seconds 10 Seconds 30 Seconds 90 Seconds 
Larger tubing, angled, fast 
 
Larger tubing, angled, slow 
 
Larger tubing, straight, fast 
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Larger tubing, straight, slow 
 
Smaller tubing, angled, fast 
 
Smaller tubing, angled, slow 
 
Smaller tubing, straight, fast 
 
Smaller tubing, straight, slow 
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As seen by the time-point pictures, the smaller tubing at an angle with faster input velocity 
resulted in complete diffusion in the shortest amount of time. The well was almost entirely diffused at 10 
seconds which was not seen for any other configuration. To understand the desired flow rate and velocity 
for laminar and turbulent flow, calculations were completed which can be seen in Appendix M. From 
these calculations, it was shown that turbulent flow would result in the fastest diffusion, however, it is 
unrealistic to reach turbulent flow because a very high velocity and volumetric flow rate (almost 2 mL/s) 
would be needed. Overall, based on calculations and experimentation, it was concluded that the smallest 
tubing and the fastest possible input rate would result in the fastest diffusion. 
5.4 Complete Design of Microscope Incubator System 
After all feasibility testing, a final design was created, shown in Figures 50, 51 and 52. A holder 
was 3D printed to organize the various parts of the design shown. A conventional plastic bin was used to 
hold the remaining components of the device including the CO2 tank and Arduino board (Figure 51). 
Wires needed to be plugged into wall sockets will exit the box away from the microscope device (Figure 
52). The individual parts and functions are shown and described in the User Manual in Appendix S. 
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Figure 50: Section of device to be placed on microscope, including modified cover and plate. Connections to control system box 
are pictured: 1) CO2 sensor wires, 2) CO2 tubing with in-line filter, 3) thermistor leads and 4) transparent heater leads 
① 
② 
③ 
④ 
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Figure 51: Container of device components on benchtop. Connections that will run through the box to the microscope device are 
circled in red 
 
Figure 52: Overall final design of control system box, showing the necessary power cords (on right) 
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6. Device Validation and Results 
After fabrication of the device, quantitative and qualitative tests were completed in order to assess 
how well the device met the initial objectives. The tests that were used to assess the success are 
summarized in Table 48. The methods and results of each test are described in each section of this 
chapter.  
Table 48: Table of Validation Testing 
Primary 
Objective 
Testing Method Data Collected 
Cell Viability 
Measuring Temperature Temperature of media in wells  
Measuring CO2 Levels CO2 level in device  
Measuring Relative Humidity 
Levels 
Relative humidity in device 
Sterility Testing Amount of contaminant growth 
3D Construct Contractility Observation of cell contractility compared to a 
control 
Imaging 
Cell Imaging on Fluorescent 
and Light Microscopes 
Image quality compared to a control 
Reproducibility 
Measuring Temperature Initial time required to heat up, variation in 
temperature in each well 
Measuring CO2 Levels Variation in CO2 throughout device 
Perfusability 
Well Diffusion Test Observation of spreading of dye being 
perfused, time until complete diffusion 
Measuring Flow Rate Difference between automated flow rate and 
non-automated flow rate  
Versatility 
3D Construct Contractility  Observation of cell contractility compared to a 
control 
Cell Imaging on Fluorescent 
and Light Microscopes 
Analysis of how well device fits on different 
microscopes 
User Friendly 
Visualization of Process Any points of difficulty, common errors 
Automation/Controls Testing Length of time controls can run for 
 
6.1 Measuring Temperature  
One goal of measuring the temperature of the overall device is to ensure reproducibility. By using 
the entire device, the effect of the alterations made to the cover and the extra material from the holder 
were taken into consideration. The test measured variation across the device. The temperature of the 
overall device should always be kept between 34 and 37°C. Any fluctuation in temperature could 
negatively affect the cells in culture resulting in inaccurate data.  
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The temperature of the device was measured using thermocouples. For each well, 3 mL of room-
temperature water was added. For the humidity wells, 3 mL of water at room temperature was added to 
each. A thermocouple was placed in the middle of each well and temperature readings over time were 
recorded using a LabVIEW Program seen in Appendix N. 
As a control for this test, cold-junction thermocouples were used. The cold-junction of the 
thermocouple was placed in ice water at 0°C. The differential in temperature that the thermocouple 
records will not be affected by changes in room temperature with this set-up. The typical cold-junction 
thermocouple set-up is shown in Figure 53.  
 
 
Figure 53: Cold-junction thermocouple diagram (“Implementing…”, 2007) 
Temperature was recorded in each well for 35 minutes. The results of these measurements can be 
seen in Figure 54. The device reached 37°C after about 15 minutes. Table 49 shows the largest difference 
in temperature between all the wells for certain time intervals after 37°C was reached. As time when on, 
this temperature range decreased. After 35 minutes, the maximum temperature difference between wells 
was 2.5°C or less.  
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Figure 54: Thermocouple readings over time for each of the 6 wells 
 
Table 49: Temperature Difference using Thermocouple for Measurement 
 
 
6.2 Measuring CO2 Levels 
It is important that the CO2 level inside the device is kept within 4 and 6% as it creates proper 
buffering of the cell culture media. This buffering is necessary to prevent the cell culture media from 
displacing or absorbing too much CO2. A 1 liter CO2 tank was obtained. This tank was attached to a 
regulator and solenoid that can be seen in Figure 55. After the CO2 system was connected to the device, 
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CO2 was released into the device controlled by the Arduino in 0.5 second spurts with a 60 second pause in 
between. 
The MH-Z16 CO2 sensor and the Logger Pro® Vernier CO2 sensor were placed in the holder 
device. The Vernier probe was placed diagonally in the device to read the CO2 in the same location as the 
other sensor as shown in Figure 56. After this was setup, the acrylic cover to the 3-D printed holder was 
placed on top and the tube connected to the CO2 system was placed in the device. The reason that the 6-
well plate was not included in this experiment is due to the large size of the Vernier sensor. All three 
apparatuses would not fit within the chamber of the holder.  
 
Figure 55: CO2 tank and regulator system setup 
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Figure 56: CO2 testing setup with device sensor below CO2 input (white), and larger Vernier sensor in device chamber 
This experiment was intended to assess the accuracy of the sensor, test the efficiency of the 
Arduino code, and test the overall functionality of automatic CO2 supply and regulation. The results, as 
shown in Figure 57, show that the system as a whole was functional as it maintained the CO2 within the 
range of 4-6%.  
 
Figure 57: CO2 measurements of device and Vernier sensors for 600 seconds 
Since both of the sensors where placed next to each other in the previously mentioned 
experiment, it validated that the CO2 sensor is accurate, however, the distribution of the CO2 throughout 
the system was not tested. In order to analyze the dispersion of CO2, the same experiment was done, only 
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the Vernier sensor was rotated to be on the other side of the chamber as the other sensor. This allows for 
analysis of CO2 at both ends of the device. The results shown in Figure 58 show that there is a difference 
in the CO2 levels at these ends of the chamber. This is due to the slow CO2 input rate. Over time, the gas 
would disperse throughout the chamber, but not within the first 1000 seconds.  
 
Figure 58: CO2 Measurements for 1000 seconds with the Vernier Sensor Inverted 
 
6.3 Measuring Relative Humidity Levels  
It is important to maintain a relative humidity of 90%-100% when conducting cell culture, so the 
media does not evaporate. Humidity levels within the device were recorded using a Logger Pro® Vernier 
humidity sensor. To use the humidity sensor, a cover with holes over each well was fabricated so that the 
humidity sensor could fit inside the device while the cover was still on. When any holes in the cover were 
not in use, they were covered with tape.  
Each of the 6 wells were filled with 3 mL of media in the 6 well and 5 mL in each humidity 
basin. The heating element was on for the duration of the experiment. The control system was also in use 
during the duration of the experiment to make sure that the temperature of the media was being kept 
between 34 and 37 °C. It is important to make sure the temperature is the same as it would be during 
standard use because a lower or higher temperature could result in a lower or higher relative humidity.  
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A control 6-well plate was also used. The control was a 6-well plate with no media or water. This 
control accounted for any changes in humidity in the room. For both the control and experimental groups, 
the humidity was measured for 1 minutes and then averaged. The humidity was measured following this 
procedure once every hour for 7 hours (Figures 59 and 60).  
 
Figure 59: Relative humidity over 7 hours in experimental plate 
 
Figure 60: Relative humidity over 7 hours in control plate 
6.4 Sterility Testing  
The device must be able to maintain sterility as defined in the constraints because any presence of 
contamination nullifies the experiment. In order to sterilize a plastic, such as polystyrene, with EtO gas, 
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certain precautions need to be taken. Only the cover of the device along with the attached perfusion 
tubing need to be sterilized with EtO because the base can be replaced with a new 6-well plate for each 
use. According to the FDA, parameters for the temperature, pressure, humidity, gas concentration, 
exposure time, and degassing should be identified to make EtO sterilization effective for the specific 
application (FDA, 2004a). After sterilization, the ethylene oxide byproduct should be measured by 
infrared absorption (Warncke, 1961) to adjust the parameters were accordingly. 
The sterility of the compressed CO2 gas that is going into the device must be considered. The 
FDA outlines guidelines for membrane filters used for air filtration. The membrane filter must be kept dry 
because condensation can cause blockage, allowing for the growth of microorganisms. Hydrophobic 
filters can be used when moisture is problematic. The FDA recommends that a filter integrity test is 
complete after use to investigate the sterility and to determine defined intervals at which the filter should 
be replaced (FDA, 2004a). For the CO2 input line an in-line Hepa Sanitary Air Filter (Dickson 
Homebrew, model #FIL90X1) was used to intercept the CO2 tank air before reaching the device. 
According to the FDA, the sterilized device was tested in an aseptic processing operation, and 
in order to validate the sterility, a microbiological growth medium can be used. This process is called 
"media fill" and is used to simulate the exposure that the 3D tissue constructs used in the device are 
exposed to (FDA, 2004a). 
Both control and experimental plates were incubated in a normal incubator to eliminate any 
superfluous variables. Therefore, the transparent heater and CO2 tank were excluded in the setup. The 
components of the device were pre-sterilized using EtO gas or by spraying with ethanol, and transferred 
to the biosafety cabinet. Media was made by supplementing Iscove’s basal media with 10% Fetal Bovine 
Serum (FBS), and adding no antibiotics or antifungals. In the biosafety cabinet, 3 mL of media (without 
cells) was injected into each well using the perfusion system. The humidity wells were filled with 3 mL of 
sterile distilled water each. The CO2 input tubing and filter were attached and the system was transferred 
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into a standard incubator for 3 days. As a control, a 6-well plate was filled with 3 mL of sterile media in 
each well and 3mL of water in the humidity wells and kept in the standard incubator. 
Contamination was checked daily for 3 days by holding the culture dishes to light to view visible 
colonies. Following a routine cell culture protocol, the media was exchanged on day 2. Additional media 
was also added via the perfusion system on the benchtop on day 2.  The plate and device was allowed to 
incubate for another day. At the end, the media was inspected for any visible growths, and the media 
color was checked. If there was any biological contamination in the device, the conditions would allow 
them unhindered growth. Each well was imaged with a visible light microscope.  
6.5 Measuring Flow Rate 
Flow rate was tested with both automated and non-automated means.  In order to demonstrate that 
automated input resulted in consistent diffusion, 1 mL of dyed water was perfused in a well of the device 
containing 3 mL of water using a syringe pump at a rate of 2mL/min. The well also contained a construct 
consisting of velum paper, gel, and 5 microthreads as per Pins Lab protocol (Chrobak et al., 2016). This 
was repeated five times and a video was taken of the dye movement. Each trial was compared and 
demonstrated that the dye flowed in a similar pattern each time. However, because the maximum flow 
rate from the syringe pump was only 2mL/min, complete well diffusion was not achieved.  
To test higher flow rates, 1 mL of dyed water was perfused in a similar manner, however, this 
time by hand at a rate of 12 mL/minute. Five trials were completed for this control. Despite inputting by 
hand, the spread of dyed water was similar for each trial. An example of the spread is shown in Figure 61 
which was taken 30 seconds after initial input of dye. As shown, the dyed water had almost completely 
covered the samples. With small shaking of the 6-well plate, the dye distributes even better as seen in 
Figure 61. Based on user input, needing to slightly shake the plate after input would be acceptable 
protocol.  
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Figure 61: 1mL of dyed water perfused at 12mL/min (left) and dyed water after shaking of 6-wel plate (right) 
6.6 Well Diffusion Test  
Diffusion throughout the entirety of each well is important because the 3D construct must receive 
the same amount of drug per area. To test device diffusion, C2C12 cell seeded fibrin constructs were 
perfused with a LIVE/DEAD stain using the system, and cell counts evaluated. C2C12 cells were used as 
a model for cardiomyocyte cells, being easier to culture and being from the muscle cell lineage. Both the 
control and experimental plates were incubated in a normal incubator to eliminate any differences using 
the heating and CO2 system on cell function. A full protocol of the Cell Dye Uptake Experiment can be 
found in Appendix O. 
To make the constructs, Pins Lab protocol was followed to make five fibrin microthreads glued to 
a vellum frame. In the biosafety cabinet, fibrin gels were cast on PDMS using Pins Lab protocol (Chrobak 
et al., 2016). Two samples were placed into the device 6-well plate, and two were used in the control 6-
well plate. The samples were perfused with 2.5 mL of the LIVE/DEAD stain (Calcein AM/Ethidium 
homodimer-1) in PBS solution. The experimental samples were perfused via the injection system on the 
benchtop (Figure 62), and the control samples injected using a serological pipette in the biosafety cabinet. 
The samples were incubated in a standard incubator for 30 minutes. 
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Figure 62: Image taken of injection perfusion of dye solutions into experimental samples 
The samples were imaged at 20X magnification in four regions for both the live stain fluorescent 
channel and dead stain channel. The diagram of the image locations taken can be seen in Figure 63. An 
example LIVE/DEAD image from control sample #1 is shown in Figure 64. Fluorescent images for 
experimental sample #1 and control sample #1 can be found in Appendix P. The images were then 
analyzed in ImageJ to obtain cell counts by splitting the channels, reducing background noise, and using 
the Make Binary and Watershed features. The size of ellipse registered by the software to count as a cell 
was kept consistent through the analyzed images. Experimental sample #2 and control sample #2 were 
omitted from the data set since the samples were not formed well, creating an uneven distribution of cells. 
Example of data obtained in the cell count is shown in Figures 65. 
 
Figure 63: Diagram of regions taken by fluorescent imaging of each sample. 
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Figure 64: Example images taken at 20X of control sample #1, Region 2. Panel “a)” shows the live stain with live cells fluorescing 
green in the fibrin gel. Panel “b)” is taken at the same location on the dead stain fluorescent channel. Dead cells in panel b) are 
fluoresced red (indicated with arrow), as well as the fibrin thread auto-fluorescing. 
 
Figure 65: Average cell counts of the four regions of experimental sample #1 and control sample #1 (n=1) for the Calcein AM live 
stain EthD-1 dead stain 
The cell count groups for the control and experimental sample were compared by a statistical T-
Test and were found to be not significant (p>0.01). There was also comparable cell counts between each 
of the four regions within each sample (p>0.01). This datum suggests that the Live/Dead stain had 
reached the same four regions using our perfusion system as a control. If there were more live and dead 
stained cells in the control group then it would indicate that the injected liquid through our perfusion 
system was not evenly distributed, which was not the case. 
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6.7 Entire Device Testing 
The device must be able to run on the benchtop for the time a user would need to image on a 
microscope. This time span is on average 8 hours as defined by the users. Therefore, the device should be 
able to function continuously for at least an 8 hour work day for multiple experiments. In that time the 
device must be controlling temperature, humidity, CO2, and maintaining sterility.  
As a final validation experiment, the entire device ran for a total of 8 hours. For proof of concept, 
C2C12-seeded fibrin constructs were fabricated in accordance with Pins Lab protocol (Chrobak et al., 
2016). First, device components were sterilized as per the User Manual in Appendix S. The constructs 
were seeded with 400,000 cells and placed in two 6-well plates for control and experimental. The 
experimental plate was incubated in the device for 8 consecutive hours on the benchtop. The control 6-
well plate was placed in the incubator for 8 hours following standard protocol. During this testing, CO2 
and temperature systems were monitored real-time using the Arduino (Figures 66 and 67). When the 8 
hours were complete, LIVE/DEAD® stain was added to both plates. The device perfusion system was 
used to inject the stain in the experimental plate. Both plates were incubated for an additional 30 minutes. 
Four representative images were taken of all constructs on the inverted fluorescent microscope (Figure 
68). Cell counts were obtained using ImageJ analysis software to compare control and experimental 
samples (Figure 69). For a more detailed protocol see Appendix S.  
 
Figure 66: Arduino board output of device CO2 sensor over 8 hours 
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Figure 67: Arduino board output of device thermistor over 8 hours 
 
 
Figure 68: Representative image of LIVE/DEAD stained C2C12-seeded constructs at same location (20X magnification) using two 
fluorescent channels: A) green, showing live cells and B) red, showing dead cells (white arrow indicating a cell) 
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Figure 69: Cell counts per construct, comparing control and experimental samples (n=6) 
6.8 Visualization of Process 
Throughout all testing, observations were made for any difficulties in the use of the device. These 
difficulties and common sources of error were recorded to provide the user with advice and tips for the 
use of the device. These tips for proper use are included in the User Manual found in Appendix S. 
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7.  Discussion   
7.1 Temperature Analysis 
 The objective for temperature regulation was to keep the entire device between 34°C and 37°C. 
Based on the temperature validation testing, it was found that during the first 30 minutes of heating up, 
the maximum difference between temperatures in the various wells was 3°C. After 30 minutes, the 
maximum temperature difference was no more than 2.5°C. With this temperature distribution, there was 
no way to completely maintain the temperature within 34 and 37°C. Based on experimentation, if the user 
keeps the device on for 30 minutes prior to imaging, temperature will be kept between 34.5°C and 37°C. 
Because cardiomyocytes contract in a very small temperature range, maintaining this range was essential 
and would be beneficial to more accurately observe contractions. 
 The main limitation the design team faced with temperature control was variability with the 
transparent heater itself. A lower temperature caused by this variability could cause less contractility. 
However, this device is more beneficial than benchtop testing that is done at room temperature alone. 
Further temperature testing was conducted with cells for a multiple day experiment. Cell survival would 
help indicate how this deviation from the desired temperature range affect the success of the device. The 
cell experiment with temperature regulation is discussed further in Section 7.3  
7.2 CO2 Analysis 
 The objective for CO2 regulation was to keep the entire device between 4% and 6% CO2. Based 
on the CO2 testing discussed in Chapter 6, the device met this requirement. It took less than 4 minutes to 
bring this device from atmospheric CO2 levels to 4%. After reaching 4%, the device was able to maintain 
CO2 levels between 4% and 6%. In addition to this test, a longer term test was completed with cells. For 
the cell experiment, cell survival and growth would help indicate how well the CO2 levels were 
maintained. Differences of media color compared to a control also indicates how well CO2 levels were 
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maintained. This experiment is discussed further in Section 7.3. Overall, proper CO2 maintenance was 
proved which ensures that the cells are in the correct pH environment to uphold viable.  
7.3 Final Device Analysis 
It was determined that the device remains sterile during cell culture. After completing the final 
validation test, it was determined that the environmental conditions in the device were stable and able to 
be maintained for the 8 hours, after an initial 30 min startup time. This means that the components of the 
control system did not impinge on each other and that the device is stable. Over the 8 hours, the 
automation and controls systems were validated through multiple methods. Levels of CO2 were checked 
to be within the 4.0-6.0% range inside the device. The CO2 data output from the Arduino was monitored 
continuously from a connected laptop via serial monitor. The CO2 level was also inferred by observing 
the media color which is indicated with the pH-sensitive dye since the gas acts as a buffer. The 
temperature system was similarly validated through the continuous thermistor reading output and cell 
viability. Similar to CO2, the graph of the temperature readings fluctuated within the desired range of 34-
37°C. The humidity was checked visually by evaluating the level of water in the humidity wells over 
time. The humidity basins did not need to be refilled over the 8+ hours of the experiment.  
When compared to the 6-well plate that was placed in the incubator, the results of the live/dead 
stain were comparable meaning that there was no contamination and that the device elicited similar 
environmental conditions as the incubator. This not only means that the device is able to function as a 
stable incubator, but also as an environment that is sterile. Final device analysis demonstrated that the 
fabricated device could be used to maintain environmental conditions for at least 8 hours at a time on the 
microscope while still allowing for drug injection and media exchange.  
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7.4 Impact Analysis 
7.4.1 Economics  
Our microscope incubator system for drug testing creates a viable method for testing on 3D tissue 
constructs. It would have an economical effect on the pharmaceutical, research, and federal guidelines 
industry. On the market, the device could help reduce the cost of pre-clinical studies, and therefore the 
production cost of pharmaceuticals. More accurate testing methods will reduce the amount of adverse 
compounds that pass through clinical trials. The screening tool provided by the device could have an 
effect on preventing the inflation of pharmaceutical costs and harmful drugs on the market.  
Currently, the pharmaceutical market is cornered by larger corporations with profit to spend on 
clinical research. A cheaper method for labs to perform pre-clinical testing would allow for smaller labs 
would have access to this equipment and have the opportunity to advance to clinical trials. Ideally this 
could lead to more compounds reaching clinical trials because of the lessened financial burden. Increase 
in the use of 3D constructs would create an influx in market for developing the most accurate in-vitro 
tissue models. This would stimulate research in fields such as microfluidics to increase construct size and 
viability. The market for devices like ours would be stimulated as companies compete to develop the most 
comprehensive testing systems for specific tissue models.  
7.4.2 Environmental Impact  
The production of the device would create a minimal impact on the environment. The largest 
effect would be the production of the plastics such as ABS to create the frame of the device. Although the 
plate bottom of the design is not re-usable, the polystyrene plate is able to be recycled. The benchtop CO2 
tank used in the device can be refilled by the manufacturer to prevent further waste. The amount of 
electricity used by the 12V device could be significant depending on the length of the experiment. 
However, with more efficient circuits the electrical waste could be moderated. 
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7.4.3 Societal Influence  
Our device will allow for more efficient testing of tissue engineered models. Three-dimensional 
tissue constructs will be brought more to the public attention as viable in-vivo models. This will affect the 
directions of biomedical research towards developing more accurate and complex models. The fields of 
Biochemistry, Microfluidics, and Cellular Biology would also be stimulated by focusing on 3D culture 
models. Using devices such as ours, more model systems could be applied to model not just healthy 
tissues, but a disease state. The added efficiency in the pre-clinical phase of drug testing would reduce the 
cost to develop new drugs. This could bring the pharmaceutical price down and allow more consumers to 
afford medication.  
7.4.4 Political Ramifications  
High medication costs as the result of inefficient and costly testing methods remain a large global 
problem. This device would make 3D constructs a viable testing method for pre-clinical drug screening, 
and ideally lower these costs. With costs of production lowered, more drugs could reach the market to 
patients. Healthcare costs for these medications, especially lifesaving ones, could be reduced. Making 3D 
constructs a routine part of pre-clinical testing will require many new regulations and guidelines. The 
FDA will need to create more detailed guidelines on the cell sources, production, standards, and uses of 
new 3D constructs for drug testing.   
7.4.5 Ethical Concerns  
The ethical aspects of this device center around it uses more than the device itself. The device 
will be beneficial ethically to society because it could limit the waste of animal models. By extension, this 
efficiency would limit the amount of clinical trial participants and consumers harmed in the pharma 
development process. On the other hand, the constructs used to the test the device were fabricated with 
animal-based fibrin which is an ethical concern for morally-sourced components. Another ethical concern 
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of the device is the source of cells for the constructs, including embryonic stem cells. If a patient's own 
cells were used in the construct it could limit the ethical concerns of cell sources. A possible topic that 
could arise with developing more complex tissue models is the line in where a tissues model would be 
considered "living"- which is an interesting consideration.  
7.4.6 Health and Safety Issue  
The device contains mechanical and electrical components that pose a moderate risk to the user. 
The solenoid electrical component function at 120V AC, so there is risk of electric shock if circuit is 
exposed. There are risks associated with pressurized carbon dioxide canisters and the overexposure of 
carbon dioxide if there is a leak. Carbon dioxide displaces oxygen when inhaled, and it can become 
dangerous over 5,000 ppm in 8 hours or 40,000 ppm immediately (NIOSH, 1976). During sterilization of 
the device using ethylene oxide (EtO) the user should follow OSHA guidelines for proper sterilization to 
avoid any exposure.  
7.4.7 Manufacturability  
The cost to manufacture this device has been considered. An objective of the device is to have the 
cost for the user significantly lower than competitors on the market. Many current market costs for 3D 
construct culture devices that also have perfusion cost at least $5000. This device utilizes a simple 3D 
printed ABS plastic frame, which is quickly produced with additive manufacturing, or casting in another 
plastic material. This device also has a pre-designed CO2 regulation system, a heater less than $100, and 
common Luer lock tubing connectors. The disposable plate design that was adapted means that the cell 
culture plate bottom is provided by the user. A difficulty that may occur for manufacturing is the angled 
tubing inlets placed on the cell culture plate cover, which would require specialized tooling or casting the 
cover as one piece of polystyrene. The estimated cost to produce this device is approximately $450. See 
Appendix Q for price breakdown.  
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7.4.8 Sustainability   
Our device design makes it sustainable in a laboratory setting. The replaceable 6-well dish and 
completely serializable design allows for many uses. Using a new 6-well bottom for each experiment also 
reduces concerns about EtO gas residue in plates after multiple sterilizations. This device is also able to 
be sustained in the 3D construct market. The field of 3D construct research is new and growing, and it 
was predicted that there will be usage of 3D tissue models for many diseases. With all of this opportunity 
in 3D constructs, there will be a need for drug testing. Since the device has a simple, cell-viable design it 
can be applied to many other 3D models, not only cardiac ones.  
7.4.9 Industry Standards 
 Various guidelines from the FDA were followed during the completion of this project. As 
discussed in Section 6.4, FDA guidelines were followed regarding correct protocol for EtO sterilization of 
a device and for the media fill test that was conducted to determine sterility (FDA, 2004a). These 
guidelines also helped in determining the correct type of membrane filter for CO2 air filtration into the 
device. (FDA, 2004a). Because the device could be used with human cell-seeded constructs in the future, 
Title 21 of the FDA was used which describes the general biological products standards. This guideline 
helped determine the proper storage and maintenance this device would need to retain. The storage aspect 
specified that the temperature within the device must be characteristic to the cell type and the 
maintenance aspect described contamination policy (US FDA, 2014).  
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8. Conclusions and Recommendations 
Validation testing was completed by culturing skeletal muscle cells in the created device and 
comparing their viability against a control cultured utilizing standard laboratory techniques. Based on 
validation testing the temperate, CO2, and humidity levels in the created device were within the desired 
ranges. The maintenance of sterility and functioning of these control systems did not impede cell 
viability. Overall, the final device was a self-contained, functioning microscope incubator system that can 
support 3D cell-seeded constructs while drug screening. This incubator system reduced the cost compared 
to other existing solutions by an order of magnitude. The device was approximately $450 to produce 
compared to the other devices on the market discussed in Section 2.2 that were upwards of $8,000.  
In the future, more testing could be completed to further validate the design. Testing with 
cardiomyocytes could be completed. Cardiomyocyte contractility is largely dependent on temperature. By 
comparing cardiomyocyte contractility with a control, the temperature of the device would be validated 
further. Through testing, it was found that the main issue with keeping temperature consistent in all wells 
of the device was due to variability in the transparent heater. It is recommended that, in the future, better 
quality transparent heaters are tested to make the temperature range of the device even smaller.  
Using cardiomyocytes would also allow for analysis of drug effects on contractions. By exposing 
cells to different pro-arrhythmic or antiarrhythmic drugs, the differences in speed and consistency of 
contractions could be monitored. Calcium voltage propagations through the cells could be monitored 
through the addition of electrodes into each well, creating a multi-well electrode array. Simple 
cardiotoxicity assays can be performed by adding drugs not for application in the heart and observing cell 
viability and function. Especially due to the high amount of cardiovascular-related adverse effects after 
market, these cardiotoxicity assays would detect any effects on contractile proteins of the cardiomyocytes. 
These changes would predict any pro- or antiarrhythmic effects of new compounds if put into the 
bloodstream, which can be fatal. Since the cardiovascular system pervades through every system of the 
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body, testing any new compound for cardiotoxicity on 3D constructs with the created microscope 
incubator device would be beneficial to the pharmaceutical industry and safety of consumers. 
In order to improve the ease of use, it is recommended that the wiring involved in the control 
system be condensed with a printed circuit board. This would make it easier for the user to handle. Also, 
adding a display to be connected to the Arduino will improve the ease of use. Doing so would allow for 
the user to visually view the recorded temperature and CO2 levels in real time. With this concept, creating 
an automatic system for data storage would allow the user to go back and view these recorded values after 
the experiment is performed. In the event that an error occurs in the control system, this would allow the 
user to know when that error occurred and for how long it occurred. 
A mobile app could also be created to enhance the ease of use. An app that records the control 
readings from the Arduino and notifies the user if anything is out of range would be very beneficial to the 
user. If an experiment undergoes issues within this device and no one is present in the lab, it could lead to 
inaccurate results. Having an app would allow the user to be notified in the event that something goes 
askew. This could prevent an experiment from failing and could allow for long term testing. Lastly, it is 
recommended that the design be modified to house a 12 or 96-well plate. Doing so would not only make 
the device high throughput, but also allow for different types of 3-D models to be placed within the 
device. Modifying the perfusion system to accommodate for these high throughput wells would be an 
even greater change, as it would allow each well to be easily perfused by a desired liquid. 
With these modifications and the success of this design, this device would be highly beneficial in 
the drug testing process, saving pharmaceutical companies a lot of time and money. 
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Appendix  
Appendix A: Client/ User Meeting Questions and Answers  
Katrina Hansen, PhD candidate in Prof. Gaudette Lab  
 
09/19/2016  
Katrina gave us advice on our Literature Review and content organization  
What kind of cardiomyocytes did you use in the CIFF Grant?  
Katrina:  
 IPS-derived cardiomyocytes used in CIFF Grant  
 These cells spontaneously contract in normal culture conditions  
 Neonatal rat cardiomyocytes can be used, but they do not contract as much  
What stains do you usually use for cardiomyocyte experiments to test viability/function?  
Katrina: Fluo-4 stains for contractions, detects the calcium flux. Calcein stains Live/Dead cells 
What microscopes do you see this device being used on?  
Katrina: All upright microscopes capable of brightfield and fluorescent imaging. Confocal 
adaptations would be an advantage  
Any advice on the CO2 perfusion setup that would be convenient for the user?  
Katrina:   
 Buy a separate CO2 cylinder that would fit on a benchtop  
 Use a regulator, which would be expensive, but are common in labs  
Any advice on the O2 regulation?  
Katrina: When the 5% CO2 is put into the device, it displaces enough oxygen to maintain the 
~21% O2 levels for cell culture  
Any advice on the sterilization of the device?  
Katrina:  
 Ethylene Oxide (EtO) would be the most convenient and fitting for the materials used  
 UV light and ethanol are other options  
------------------------------------------------------------------------------------------------------------------------------- 
10/04/2016   
What environmental conditions affect the contractility of cardiomyocytes?   
Katrina:   
 The CO2 levels, temperature, and contents of media  
 Lower temperatures (between 30 and 37 °C) are fine for cells, they just may not contract as 
spontaneously  
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What are voltage and calcium sensitive dyes that are used?  
Katrina:  
 Voltage sensitive dyes: Arclight spectrum, Di-2-Anepps (4 and 8 as well)  
 Voltage sensitive dyes can be used to test different drug solubility mechanisms because they act as 
different timepoints  
 Calcium-sensitive dye: Flo-4  
Do you have any other downsides to current voltage testing methods on cardiomyocytes?  
Katrina:  
 Multi-electrode arrays (MEA's): expensive and destructive, may cause changes in contractility  
 Patch-clamp method: alo destructive to the cells and can affect function  
What are the different times for contractility for cultured cardiomyocyte strains?  
Katrina:  
 Neonates: 14 days, IPS (Induced pluripotent stem cells): 21 days  
What are the average size of the 3D constructs used in lab?  
Katrina:  100-150 microns, cells in a gel: 150 microns, will be able to fit in a 6-well plate well  
How long should the device work for?  
Katrina: 3 weeks  
How many mL of media are commonly used in cardiomyocyte culture in a 6-well plate well?  
Katrina: Usually between 1-1.5 mL of media  
 
------------------------------------------------------------------------------------------------------------------------------- 
 10/28/2016   
   
Does the inside of the well need to support all types of 3D cell models? (Ex: the hooks for fibrin 
microthread scaffolds)   
Katrina: No, it will be modified by the user. Can use Megan Chrobak's constructs as a proof of 
concept.  
Would it be beneficial to add electrical stimuli to our project goal?   
Katrina: Look into electrical stimuli and keep it in mind. Doesn’t have to be included because it 
may be out of the scope of the project.  
Will we be only using Calcein AM staining as a proof-of-concept?  
Katrina: Yes, but Fluo-4 can be used as an additional method of testing  
What CO2 lab source could we utilize?  
Katrina: Buy small cylinder and regulator ($$$)--> common lab equipment   
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Is the O2 and humidity levels in the atmosphere sufficient?  
Katrina: Need to test for this and prove  
What kind of microscopes are usually in lab/used for imaging? Do you image through the sample?   
Katrina: All upright bright field microscopes.. Don’t worry about confocal   
Would you rather the device be reusable or disposable?  
Katrina: Reusable. Doesn’t need to have a coating. Can be resterilized, so it would be cheaper.  
Are sensors for each well necessary?  
Katrina: 1 universal sensor to validate--> use temperature probe in each well during testing.  
How will the device be sterilized? Will running bleach through be enough?  
Katrina:   
 EtO gas sterilize, UV light, or ethanol    
 EtO is electronic/sensor friendly. Can make the pieces detachable for easier sterilizability  
Any other materials to use other than polystyrene?  
Katrina: Polystyrene can't be autoclaved, but it is common enough for cell culture that it is good 
to use.  
------------------------------------------------------------------------------------------------------------------------------- 
11/14/2016    
   
What locations inside the well should we test for temperature?    
Katrina:    
 Top view center of well: top, middle, bottom height  
 Top view side of well: top, middle, bottom height  
How many times are the cell culture plates EtO sterilizable?  
Katrina: less than 50 times, however the user would only sterilize the plate < 20 times  
Is it ok to store the device in a cell culture incubator between testing?  
Katrina: Yes  
Do the holes between the wells in a cell culture plate have any use?  
Katrina: Probably not, but call manufacturer  
How would we 3D print a PDMS mold for a heating mat?  
Katrina: Need to consider the chamber angle (>90° optimal) so that the PDMS does not rip when 
it is taken out  
Would a top-down perfusion system be acceptable?  
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Katrina: Yes, would need to make sure that the tubes are sealed in the cover and that the 
apparatus obscured as little of viewing window as possible.  
 
------------------------------------------------------------------------------------------------------------------------------- 
12/05/2016   
   
Advice on the CO2 regulation control system?   
Katrina: Benchtop and solenoid would work, check how normal incubators regulate CO2. The 
control system may not be "on board" and could be replicated.  
Would the manifold design for tubing collection be convenient for the user?  
Katrina: Yes, since the tubing inputs would be organized and stationary. However the tubing 
system must remain sterile and not disconnect during transport. Therefore the top half of the 
manifold could lift off, or the manifold would need to hold onto the 6-well somehow without 
adding height during imaging.  
 We talked more through the manifold idea and what would be most convenient for a user  
What is the microscope that would be used for fluorescence normally in lab?  
Katrina: Leica upright DMI-1 microscope, working distance 40-50 um  
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Appendix B: Objective Brainstorming  
 
Objective brainstorming tree in A-term: 
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Appendix C: Primary Objectives Pairwise Comparison Charts  
 
Designer PCC by Rachel Connolly, Heather Stratica, and Marianne Kanellias: 
  
  
Client PCC by George Pins: 
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User PCC by Megan Chrobak: 
   
 
User PCC by Katrina Hansen: 
  
  
 
 
  
127 
 
Appendix D: Secondary Objective Pairwise Comparison Charts   
Cell Viability Secondary Objectives:   
Designer PCC by Connolly, Heather Stratica, Marianne Kanellias: 
   
Client PCC by George Pins: 
   
User PCC by Megan Chrobak: 
   
User PCC by Katrina Hansen:   
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Reproducibility Secondary Objectives:   
Designer PCC Rachel Connolly, Heather Stratica, Marianne Kanellias: 
   
Client PCC by George Pins:   
   
User PCC by Megan Chrobak: 
   
User PCC by Katrina Hansen:   
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Versatility Secondary Objectives:   
Designer versatility PCC by Rachel Connolly, Heather Stratica, Marianne Kanellias: 
   
Client versatility PCC by George Pins:   
    
User versatility PCC by Megan Chrobak:  
   
User versatility PCC by Katrina Hansen:   
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Appendix E: Design Team Gantt Chart  
Full-year Gantt Chart from A-term to D-term (Chart is separated by term for readability): 
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Appendix F: Metrics Rubric 
 
This appendix is the rubric that was used to rate elements of the decision matrices completed in 
Chapter 4. The description of specifications that each element needed to meet for each objective 
and sub-objective are detailed below: 
 
Objectives 
1. Cell Viability (26%) 
a. CO2 Regulation 
Units: The ability to have a controllable CO2 source 
1- Cannot maintain CO2 between 4% and 6%  
2- Manual control between 4% and 6% and cannot run for 3 weeks 
3- Automatic control between 4% and 6%, but cannot run for 3 weeks 
4- Manual control that can run for 3 weeks between 4% and 6% 
5- Automatic control that can run for 3 weeks between 4% and 6% 
 
 
b. Temperature Regulation 
Units: The ability to have a controllable temperature source for up to 3 weeks that stays at a temperature 
of 34 to 37°C 
1- Cannot maintain temperature between 34 and 37°C 
2- Manual control between 34 and 37°C and cannot run for 3 weeks 
3- Automatic control between 34 and 37°C, but cannot run for 3 weeks 
4- Manual control that can run for 3 weeks between 34 and 37°C 
5- Automatic control that can run for 3 weeks between 34 and 37°C 
 
c. Humidity Regulation 
Units: The ability to have a controllable Humidity source 
1- Cannot maintain relative humidity between 90% and 100% 
2- Manual control between 90% and 100% and cannot run for 3 weeks 
3- Automatic control between 90% and 100%, but cannot run for 3 weeks 
4- Manual control that can run for 3 weeks between 90% and 100% 
5- Automatic control that can run for 3 weeks between 90% and 100% 
 
d. O2 Regulation 
Units: The ability to have a controllable O2 source 
1- Cannot maintain O2 level between 4% and 12% 
2- Manual control between 4% and 12% and cannot run for 3 weeks 
3- Automatic control between 4% and 12%, but cannot run for 3 weeks 
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4- Manual control that can run for 3 weeks between 4% and 12% 
5- Automatic control that can run for 3 weeks between 4% and 12% 
 
2. Imaging (21%) 
a. Transparent for Fluorescent and Light Microscopy 
Units: The ability to image through the material 
1- Material is opaque 
2- Material is less than 85% transparent 
3- Material has a refractive index lower than 1.52 but is not at least 85% transparent 
4- Material is at least 85% transparent but does not have a refractive index lower than 1.52 
5- Material is at least 85% transparent and has a refractive index lower than 1.52 
 
b. Allows for Continuous Imaging 
Units: The ability to have continuous imaging without decreasing quality  
1- No imaging could occur 
2- Requires unit outside of microscope stage and does impede imaging 
3- Requires unit outside of microscope stage but does not impede imaging 
4- Fits on microscope stage, but has less options for placement to allow for imaging 
5- Fits on microscope stage and does not impede imaging in any location 
 
3. Reproducibility (20%) 
a. Precise Temperature 
Units: Temperature reaches desired temperature within +/- 1°C 
1- Does not reach desired temperature range 
2- Allows temperature to reach desired temperature within +/- 4°C 
3- Allows temperature to reach desired temperature within +/- 3°C 
4- Allows temperature to reach desired temperature within +/- 2°C 
5- Allows temperature to reach desired temperature within +/- 1°C 
 
b. Accurate Temperature 
Units: Temperature reading is representative of actual temperature of each well 
1- Results in temperature reading that is not representative of any well 
2- Results in temperature reading that is representative of most wells and uneven heating of 
content 
3- Results in temperature reading that is representative of most of the wells and their content 
4- Results in temperature reading that is representative of all wells but uneven temperature of 
content 
5- Results in temperature reading that is representative of all wells and their content 
 
c. Precise CO2 Level 
Units: CO2 reaches desired percentage with +/- 1 % 
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1- Does not reach desired temperature range 
2- Allows CO2 to reach desired CO2 within +/- 4 % 
3- Allows CO2 to reach desired CO2 within +/- 3 %  
4- Allows CO2 to reach desired CO2 within +/- 2 % 
5- Allows CO2 to reach desired CO2 within +/- 1 % 
 
d. Accurate CO2 Level 
Units: CO2 reading is representative of actual CO2 level throughout 
1- Results in CO2 reading that is not representative of any well 
2- Results in CO2 reading that is representative of most wells but uneven heating of content 
3- Results in CO2 reading that is representative of most of the wells and their content 
4- Results in CO2 reading that is representative of all wells but uneven heating of content 
5- Results in CO2 reading that is representative of all wells and their content 
 
e. Regular Contractility 
Units: Device does not induce changes in normal cardiomyocyte contractility 
1- Will cause cell death 
2- Adverse effects on cell contractility compared to a control 
3- Possible effects on cell growth and contractility compared to a control 
4- Possible adverse effect on cell growth, but not contractility, compared to a control 
5- No effect on cells 
 
4. Perfusability (16%) 
a. Controllable Flow Rate 
Units: Flow rate is within 5% of inputted value 
1- Does not reach desired flow rate 
2- Allows flow rate to reach desired flow rate within +/- 10% for most wells 
3- Allows flow rate to reach desired flow rate within +/- 5 % for most wells 
4- Allows flow rate to reach desired flow rate within +/- 10 % for all wells 
5- Allows flow rate to reach desired flow rate within +/- 5 % for all wells 
 
b. Complete Well Diffusion 
Units: Inputted flow rate is consistent for each well and liquid diffuses throughout well 
1- No flow is allowed through any wells and thus no diffusion 
2- Liquid perfusion results in minimal well diffusion 
3- Liquid perfusion results in average well diffusion 
4- Liquid perfusion results in moderate well diffusion 
5- Liquid perfusion results in complete well diffusion 
 
 
5. Versatility (12%) 
a. Can be used for 3D Tissue Culture 
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Units: Device can fit desired 3D construct and support its cell viability  
1- Does not support any tissue culture 
2- Can only be used for 2D culture 
3- Can fit and support 3D constructs only smaller than 15x15x.2 mm 
4- Can fit and support 3D constructs 15x15x.2 mm 
5- Can fit and support 3D constructs larger than 15x15x.2 mm 
 
a. Multiple Wells 
Units: Device contains desired amount of wells 
1- No wells 
2- Single well 
3- Two to five wells 
4- 6 wells 
5- More than 6 wells 
 
b. Multiple Inputs 
Removed from analysis due to low scoring based on secondary objective analysis seen in Appendix D.  
 
c. Adaptable to Many Microscopes 
Units: Device can perform all functions on desired microscope(s) 
1- Cannot be used on any microscope 
2- Bulky and can only be used on one specific microscope 
3- Can only be used on one specific microscope 
4- Bulky but transferable to most inverted microscopes 
5- Transferable to most inverted microscopes 
 
6. User Friendly (2.5%) 
a. Safe 
Units: Amount of harm to user 
1- Will definitely harm user 
2- High likelihood of harming user even with caution 
3- Caution needed when using device 
4- Minimal caution needed when using device 
5- No harm to user 
 
b. Easy to Use 
Units: Amount of tasks user needs to perform 
1- Many manual tasks during use and hard to clean and sterilize 
2- Many manual tasks during use but easy to clean and sterilize 
3- Minimal manual tasks during use but harder to clean and sterilize 
4- Minimal manual tasks during use and easy to clean and sterilize 
5- Fully automated during use and easily cleaned and sterilized 
136 
 
 
7. Cost Effective (2.5%) 
a. Market Value vs. Production Cost 
Units: Device market value exceeds the cost of production 
1- Device would produce a negative financial gain  
2- Device would produce no profit 
3- Device would produce minimal profit 
4- Device would produce average profit 
5- Device would produce maximum profit 
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Appendix G: Decision Matrices 
 
Heat Source: 
 
CO2 Source: 
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Humidity Source: 
 
Perfusion System: 
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Appendix H: Nichrome Wire Voltage Calculation 
 
Resistivity calculations were completed for the nichrome wire used. This determined the voltage 
necessary to heat the wire to 39°C. The temperature goal was slightly higher than 37°C because the wire 
would have to heat both the 6-well plate and the liquid within. The wire that was used had a resistivity of 
2.083 Ω/m and the total length was recorded to be 0.61m. This means that the resistance of the wire at 
room temperature (~21°C) was 1.27Ω. Room temperature is 18°C lower than the desired temperature 
value. Using the nichrome wire specification sheet, resistance rises with temperature and current. Also, 
current and temperature change in a 4/5 ratio. The lowest temperature with a recorded current was 400°F. 
Using this current (3.58A) and Ohm’s Law, the voltage was calculated:  
 
𝑉 =  𝐼 ∗ 𝑅 =  (3.58𝐴) ∗ (1.27 Ω)  =  4.55𝑉  
 
It was determined that 4.55V would be needed to heat the wire to 400°F. By using this information, it is 
possible to determine the voltage required at 39°C (102°F). Since this is about one quarter of 400°F, the 
current used in the equation above must be divided by 5 leading to the following equation:  
 
𝑉 =  (𝐼/5) ∗ 𝑅 =  (3.58𝐴/5) ∗ (1.27 Ω)  =  0.9093𝑉  
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Appendix I: Heat Transfer Calculations 
 
Goal: To calculate if a 12V power supply for the transparent heater provides a sufficient heat flux to the 
device to heat up to 37°C. This was completed by analyzing the heat transfer in a single well.  
 
Known:  
Measured Resistance of the Transparent Heater:   R = 15Ω 
Voltage to Transparent Heater:     V = 12V 
Surface Area of Well Bottom:     As(Well) = 9.6 cm2 = .00096m2 
Surface Area of Transparent Heater:    As(Heater) = 9.6 cm2 = .0162m2 
Specific Heat of Polystyrene:     cp(Poly) = 1.4 J/g°C 
Specific Heat of Water:      cp(Water) = 4.186 J/g°C 
Density of Polystyrene:      p(Poly) = 1.04 g/cm3 
Density of Water:      p(Water) = 1.00 g/cm3 
Volume of Polystyrene:     V(Poly) = 1.22 cm3 
Volume of Water:      V(Water) = 3.00 cm3 
 
Calculate the Power: 
𝑉 = 𝐼𝑅 
𝐼 =
12𝑉
15𝛺
=  .8𝐴 
𝑃 = 𝐼𝑉 
𝑃 = (. 8𝐴) ∗ (12𝑉) = 9.6𝑊 
 
Calculate the Heat Flux: 
𝑞′ = 𝑄′/𝐴𝑠 
𝑞′ =
𝑃
𝐴𝑠(𝐻𝑒𝑎𝑡𝑒𝑟)
=  
9.6𝑊
. 0162𝑚3
 
 
Calculate Joules Required for Polystyrene to Heat from 25°C to 37°C: 
𝑀𝑎𝑠𝑠 =  𝑀(𝑃𝑜𝑙𝑦) = 𝑝(𝑃𝑜𝑙𝑦) ∗ 𝑉(𝑃𝑜𝑙𝑦) 
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𝑀(𝑃𝑜𝑙𝑦) = (
1.04𝑔
𝑐𝑚3
∗ 1.22𝑐𝑚3) = 1.27𝑔 
𝑐𝑝(𝑃𝑜𝑙𝑦) ∗ 𝑀(𝑃𝑜𝑙𝑦) ∗ (∆𝑇) = 𝐽𝑜𝑢𝑙𝑒𝑠 
1.4𝐽
𝑔 ∗ 𝑐𝑚3
∗ (1.27𝑔) ∗ (37℃ − 25℃) = 21.336 𝐽 
 
Calculate Joules Required for Polystyrene to Heat from 25°C to 37°C: 
 
𝑀𝑎𝑠𝑠 =  𝑀(𝑊𝑎𝑡𝑒𝑟) = 𝑝(𝑊𝑎𝑡𝑒𝑟) ∗ 𝑉(𝑊𝑎𝑡𝑒𝑟) 
𝑀(𝑊𝑎𝑡𝑒𝑟) = (
1.00𝑔
𝑐𝑚3
∗ 3.00𝑐𝑚3) = 3.00𝑔 
𝑐𝑝(𝑊𝑎𝑡𝑒𝑟) ∗ 𝑀(𝑊𝑎𝑡𝑒𝑟) ∗ (∆𝑇) = 𝐽𝑜𝑢𝑙𝑒𝑠 
4.186𝐽
𝑔 ∗ 𝑐𝑚3
∗ (3.00𝑔) ∗ (37℃ − 25℃) = 150.696 𝐽 
 
Set Up a Ratio to Determine Time Required to Reach 37°C: 
Note: Wattage for the entire transparent heater will be divided by 2 because it transfers heat to the top and 
bottom. 
𝐽𝑜𝑢𝑙𝑒𝑠 𝑅𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑓𝑜𝑟 𝑃𝑜𝑙𝑦
(𝑥 𝑠𝑒𝑐𝑜𝑛𝑑𝑠) ∗ (𝐴𝑠(𝑊𝑒𝑙𝑙))
=
𝑃𝑜𝑤𝑒𝑟 𝑓𝑟𝑜𝑚 𝐻𝑒𝑎𝑡𝑒𝑟 
𝐴𝑆(Heater)
 
21.336𝐽
(𝑥 [𝑠𝑒𝑐𝑜𝑛𝑑𝑠]) ∗ (. 00096𝑚3)
=
4.8𝑊
. 0162𝑚2
 
𝑥 = 75 𝑠𝑒𝑐𝑜𝑛𝑑𝑠 
 
𝐽𝑜𝑢𝑙𝑒𝑠 𝑅𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑓𝑜𝑟 𝑊𝑎𝑡𝑒𝑟
(𝑥 𝑠𝑒𝑐𝑜𝑛𝑑𝑠) ∗ (𝐴𝑠(𝑊𝑒𝑙𝑙))
=
𝑃𝑜𝑤𝑒𝑟 𝑓𝑟𝑜𝑚 𝐻𝑒𝑎𝑡𝑒𝑟 
𝐴𝑆(Heater)
 
150.696𝐽
(𝑥 [𝑠𝑒𝑐𝑜𝑛𝑑𝑠]) ∗ (. 00096𝑚3)
=
4.8𝑊
. 0162𝑚2
 
𝑥 = 529.8 𝑠𝑒𝑐𝑜𝑛𝑑𝑠 = 8.83 𝑚𝑖𝑛𝑢𝑡𝑒𝑠 
Based on these calculation, it would take approximately 10 minutes for this system to heat up to 37 
degrees Celsius. This calculation does not take into account the convection from the sides of the wells that 
would cause heat loss.   
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Appendix J: Preliminary Temperature Distribution Testing 
 
EXPERIMENT 1 
Thermistor: Original 
Arduino Temperature Range: 35-35.5 °C 
Thermistor Placement: Well 7 
EXPERIMENT 2 
Thermistor: Replacement 
Arduino Temperature Range: 36-36.5 °C 
Thermistor Placement: Well 2 
EXPERIMENT 3 
Thermistor: Replacement 
Arduino Temperature Range: 36-36.5 °C 
Thermistor Placement: Well 1 
EXPERIMENT 4 
Thermistor: Replacement (With Updated Calibration) 
Arduino Temperature Range: 36-36.5 °C 
Thermistor Placement: Well 2 
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Appendix K: Fluorescence Imaging Additional Results 
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Appendix L: CO2 Pressure Calculations 
 
 
 Determine volume of 20g of CO2 gas in the Atmosphere: 
pCO2= 1980g/m3 
 
1980𝑔
1𝑚3
=  
20 𝑔
𝑥 𝑚3
 
𝑥 = 10100𝑚𝐿 
 
 Use Boyle’s Law to Find Pressure of CO2 Tank (Assume the temperature remains constant): 
 
Va = Volume of 20g CO2 in Atmosphere = 10100 mL 
Pa = Pressure of CO2 in Atmosphere = 14.7 psi 
Vt = Volume of CO2 in Tank = 30 mL 
Pt = Pressure of CO2 in Tank = Unknown 
 
𝑃𝑎 ∗  𝑉𝑎 = 𝑃𝑡 ∗ 𝑉𝑡 
14.7 𝑝𝑠𝑖 ∗  10100 𝑚𝐿 = 𝑃𝑡 ∗ 30 𝑚𝑙 
𝑷𝒕 = 𝟒𝟗𝟒𝟗 𝒑𝒔𝒊 
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Appendix M: Flow Calculations 
 
Reynold’s Number: 
Reynold’s number is a dimensionless value that is used to represent the type of flow that is 
occurring. The equation for Reynold’s number can vary based on the shape over which there is flow. The 
equation below shows the general equation for Reynold’s number. L is the characteristic length that 
changes based on geometry. In the case of a circular pipe, L is the diameter.  
𝑅𝑒 (𝑔𝑒𝑛𝑒𝑟𝑎𝑙) =
𝜌𝑉𝐿
𝜇
 
𝑅𝑒 (𝑐𝑖𝑟𝑐𝑢𝑙𝑎𝑟 𝑝𝑖𝑝𝑒) =
𝜌𝑉𝐷
𝜇
 
 
The variables for the above equations are: 
 
𝑅𝑒 = 𝑟𝑒𝑦𝑛𝑜𝑙𝑑𝑠 𝑛𝑢𝑚𝑏𝑒𝑟 [𝑛𝑜𝑛𝑑𝑖𝑚𝑒𝑛𝑠𝑖𝑜𝑛𝑎𝑙]  
𝜌 = 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 [
𝑘𝑔
𝑚3
]  
𝑉 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑓𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 [
𝑚
𝑠
] 
𝐷 = 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 [𝑚] 
𝜇 = 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 [
𝑘𝑔
𝑚𝑠
] 
 
Based on the Reynold’s number, flow can be classified as either laminar or turbulent. There is also a 
transitional region between these two types of flow. The following are the ranges that define laminar, 
transitional, and turbulent flow: 
𝑅𝑒 < 2300 = 𝑙𝑎𝑚𝑖𝑛𝑎𝑟 
2300 < 𝑅𝑒 < 4000 = 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛𝑎𝑙 
𝑅𝑒 > 4000 = 𝑡𝑢𝑟𝑏𝑢𝑙𝑒𝑛𝑡 
The following values are for water which can be used to model the flow in the device. The following 
values also include the value for the diameter of the tubing used in the device.  
𝜌(𝑤𝑎𝑡𝑒𝑟) = 1000 𝑘𝑔/𝑚3  
𝜇 (𝑤𝑎𝑡𝑒𝑟 𝑎𝑡 36 °𝐶) = .714 ∗ 10−3  
𝑘𝑔
𝑚𝑠
 
𝐷(𝑡𝑢𝑏𝑖𝑛𝑔) = .00086 𝑚  
148 
 
Based on these constants, the velocity of the flow can be determined if turbulent flow is desired. 
Turbulent flow is preferred because as seen in the Figure below, dye that exited the tube that had 
turbulent flow resulted in a more winding path that would result in better and quicker mixing and 
diffusion (Çengel, & Cimbala, 2006).  
 
 
To calculate the required velocity, the Reynold’s number is set to 4000 and thus: 
4000 =
(1000
𝑘𝑔
𝑚3
) ∗ (𝑉) ∗ (.086𝑚)
. 714 ∗ 10−3 𝑘𝑔/𝑚𝑠
 
𝑉 = 3.3209 𝑚/𝑠 
The value used for viscosity in the equation above came from an interpolation of values from Engineering 
Toolbox (1), 2016. This interpolation can be seen below.  
(40°𝐶 –  30°𝐶)
(.653 ∗ 10−3
𝑘𝑔
𝑚𝑠) − (.798 ∗ 10
−3 𝑘𝑔
𝑚𝑠)
=
(36°𝐶 − 30°𝐶)
𝑥 − (.798 ∗ 10−3
𝑘𝑔
𝑚𝑠)
 
𝑥 =  .714 ∗ 10−3  
𝑘𝑔
𝑚𝑠
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Volumetric Flow Rate: 
The needed velocity calculated above can be converted in to a volumetric flow rate. The equation 
for this can be seen below, where V is still average velocity. Using the value for the radius of the tubing 
in the device and the velocity required, the volumetric flow rate (Q) can be calculated.  
𝑄 = 𝐴𝑉 
 
𝐴 = 𝜋𝑟2 
𝐴 = 𝜋(.0005𝑚)2 = 7.9 ∗ 10−7𝑚2 
 
𝑄 = (7.9 ∗ 10−7𝑚2) ∗ (3.3209
𝑚
𝑠
) 
𝑄 =  1.929 ∗ 10−6
𝑚3
𝑠
= 1.929
𝑚𝐿
𝑠
 
 
Based on this calculation, using the tubing in the device, the volumetric flow rate would have to 
be almost two 2mL per second. This is very fast and not a viable option. In conclusion, it can be 
determined that turbulent flow cannot be achieved in the device, however, the fast the rate, the better.  
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Appendix N: LabView Program 
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Appendix O: Cell Dye Uptake Protocol 
 
Cell Dye Uptake Experiment Protocol 
 
Goal: Demonstrate that this perfusion system distributes a dye/drug solution evenly around a cellular 
construct consistent with a control.  
 
Overview: Sample constructs will be seeded with C2C12 cells in gel form. Live/Dead stain solution will 
be perfused through this device, as well as into a sample 6-well plate. The stain uptake of the cells will be 
determined through fluorescent microscopy to ensure consistency with control.  
 
Materials:   
 Gel Formula:   
o Fibrinogen aliquot, frozen (70 mg/mL)   
o Thrombin aliquot, frozen (40 mg/mL)   
o Small Styrofoam box with ice   
o Sample constructs (e.g. Fibrin construct: five fibrin threads glued to vellum frame    
o 0.1% Pluronics in water   
o Square of sheet PDMS that fits samples beside each other   
o 1.5 mL centrifuge tubes for casting gels (each gel formula makes 2 gels (See Step 12.))   
 Passaged C2C12 cells   
 Distilled (DI) water   
 DPBS    
 70% Ethanol in water   
 0.25% Trypsin solution   
 C2C12 Cell culture media (with PS and amphB)   
  LIVE/DEAD Viability/Cytotoxicity (Calcein AM and Ethidium homodimer-1 (EthD-1)) stain kit 
by Molecular Probes    
 
Procedure:   
1. Passage C2C12 cells at least three days before experiment.   
2. Sterilize equipment at least the day before the experiment:   
a. Autoclave forceps, pipette tips, PDMS piece, Pluronic solution, DPBS, and media.   
b. Sterile filter Fibrinogen and Thrombin aliquots   
c. Sterilize sample constructs by re-hydrating in DI water for 30 minutes in a 6-well plate in 
the hood. Aspirate the water and add 70% Ethanol to cover for a minimum of 2 hours. Rinse 
the 70% Ethanol from samples with DI water three times, letting them sit in DI water for 5 
minutes before aspirating. Prop on side of wells to dry.   
3. On day of experiment, begin soaking one side of the PDMS in a shallow dish of 0.1% Pluronics 
for 1 hour.   
4. Re-hydrate construct samples in PBS for 1 hour.   
5. Remove the Fibrinogen, Thrombin, and Trypsin from freezer and let thaw at room temperature. 
Place Trypsin in 37°C water bath after thawed for around 5 minutes.   
6. Aspirate the C2C12 media and trypsinize cells by adding 5 mL of the 0.25% Trypsin solution to 
the cell culture flask. Wait 2-3 minutes or until cell detachment can be seen with a microscope.   
7. Neutralize Trypsin by adding 5 mL of media to the flask for a total volume of 10 mL.   
8. Take around 10 μL of cell suspension to load a hemocytometer and count cells.   
9. Spin cell culture suspension in centrifuge at 1000 rpm for 5 minutes.   
10. While suspension is in centrifuge, calculate the resuspension volume (mL) with the following 
formula to achieve 600,000 cells per scaffold:   
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11. Suspend cell pellet with calculated volume. Place in Styrofoam box with ice along with thawed 
Fibrinogen and Thrombin aliquots.   
12. Place samples on Pluronics-coated side of PDMS around 1 cm apart. Secure samples by pressing 
down lightly only on the frames.   
13. Cast gels onto constructs (formula casts 2 gels, 350 μL total):   
a. Combine 238 μL of cell suspension and 98 μL Fibrinogen inside a centrifuge tube. 
Prepare a pipette set to 175 μL for next step.   
b. Add 14 μL of Thrombin and quickly mix with pipette. Transfer 225 μL of gel onto each 
sample, spreading gel evenly across threads (see Figure 1 for example of setup).   
 
c. Transfer PDMS with gel samples in the 1-well plate to incubator to polymerize for 30 
minutes.   
14. Follow Example Dilution Protocol of LIVE/DEAD stain kit to make 10 mL of 2 μM calcein AM 
and 4 μM EthD-1 solution:   
a. Remove reagents from freezer and allow thawing to room temperature. Keep away from 
light for rest of procedure by wrapping in aluminum foil or turning off hood light.   
b. Add 20 μL of EthD-1 stock to 10mL of sterile DPBS and vortex.   
c. Transfer 5 μL of Calcein AM stock to the 10 mL Ethd-1 solution and vortex.   
15. Rinse samples with DPBS then add 2.5 mL of the stain solution to each sample well. Incubate for 
30 minutes to set stain.   
16. Image with fluorescent microscopy and record results. 
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Appendix P: Fluorescent Images from Dye Uptake Perfusion Experiment 
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Appendix Q: Material Costs 
 
Theoretical Cost of Device 
Part 
Cost 
(USD) Quantity  
Needs 
Replacement? 
6 Well Plate 2.91 1 Y 
Thermistor 1.45 1 N 
CO2 Sensor 69.95 1 N 
Arduino 24.95 1 N 
Transparent Heater 62.50 1 N 
6 Well Plate Cover 2.91 1 N 
CO2 Regulator and Solenoid 130.00 1 N 
CO2 Canister 69.99 1 Y 
3D Printed Holder 47.08 1 N 
Tubing (4" piece) 2.88 6 N 
Male Luer Lock Injection Site 0.42 6 Y 
Wall Power Supply Adapter 12.00 1 N 
Acrylic Cover 4.00 1 N 
CO2 Filter 6.03 1 Y 
Loctite Tape (1" piece) 0.08 6 N 
Relay 1.60 2 N 
Female Luer Lock  0.11 6 N 
    Total Cost of Device: $457.91 
  Cost per Use: 11.46 
  Cost of Replacement CO2 Canister (not often): 69.99 
   
 
  
157 
 
Appendix R: Entire Device Testing Protocol 
 
Goal: Demonstrate that this device maintains viability of cellular constructs consistent with a control on 
the benchtop continuously for at least 8 hours. 
Overview: Sample constructs will be seeded with C2C12 cells in gel form. Control plate will be placed in 
standard incubator while experimental plate will be put in this device on the benchtop. Live/Dead stain 
solution will be added to control plate and perfused through the device at the end. The stain uptake of the 
cells will be determined through fluorescent microscopy to ensure consistency with control. 
Materials: 
- Microscope Incubator Device 
 
- Standard laptop with Arduino installed 
- Gel Formula: 
o Fibrinogen aliquot, frozen (70 mg/mL) 
o Thrombin aliquot, frozen (40 mg/mL) 
o Small Styrofoam box with ice 
o Sample constructs (e.g. Fibrin construct: five fibrin threads glued to vellum frame  
o 0.1% Pluronics in water 
o Square of sheet PDMS that fits samples beside each other 
o 1.5 mL centrifuge tubes for casting gels (each gel formula makes 2 gels (See Step 12.)) 
- Passaged C2C12 cells 
- Distilled (DI) water 
- DPBS  
- 70% Ethanol in water 
- 0.25% Trypsin solution 
- C2C12 Cell culture media (with PS and amphB) 
-  LIVE/DEAD Viability/Cytotoxicity (Calcein AM and Ethidium homodimer-1 (EthD-1)) stain kit 
by Molecular Probes  
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Procedure: 
1. Passage C2C12 cells at least three days before experiment. 
2. Sterilize equipment at least the day before the experiment: 
a. Autoclave: Device acrylic cover, device modified 6-well plate cover, device CO2 tubing 
and sterile filter, forceps, pipette tips, PDMS piece, Pluronic solution, DPBS, and media. 
b. Sterile filter Fibrinogen and Thrombin aliquots 
c. Sterilize sample constructs by re-hydrating in DI water for 30 minutes in a 6-well plate in 
the hood. Aspirate the water and add 70% Ethanol to cover for a minimum of 2 hours. 
Rinse the 70% Ethanol from samples with DI water three times, letting them sit in DI 
water for 5 minutes before aspirating. Prop on side of wells to dry. 
3. On day of experiment, begin soaking one side of the PDMS in a shallow dish of 0.1% Pluronics 
for 1 hour. 
4. Re-hydrate construct samples in PBS for 1 hour. 
5. Remove the Fibrinogen, Thrombin, and Trypsin from freezer and let thaw at room temperature. 
Place Trypsin in 37°C water bath after thawed for around 5 minutes. 
6. Aspirate the C2C12 media and trypsinize cells by adding 5 mL of the 0.25% Trypsin solution to 
the cell culture flask. Wait 2-3 minutes or until cell detachment can be seen with a microscope. 
7. Neutralize Trypsin by adding 5 mL of media to the flask for a total volume of 10 mL. 
8. Take around 10 μL of cell suspension to load a hemocytometer and count cells. 
9. Spin cell culture suspension in centrifuge at 1000 rpm for 5 minutes. 
10. While suspension is in centrifuge, calculate the resuspension volume (mL) with the following 
formula to achieve 400,000 cells per scaffold: 
400,000 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑔𝑒𝑙
(68% 𝑜𝑓 𝑔𝑒𝑙 𝑐𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡𝑠)𝑥(150𝜇𝐿 𝑓𝑜𝑟 𝑔𝑒𝑙)
=
𝐶𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 𝑜𝑏𝑡𝑎𝑖𝑛𝑒𝑑 𝑖𝑛 𝑆𝑡𝑒𝑝 7.
𝑥
 
 
400,000
(0.68)(150)
=
𝐶𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
𝑥
 
11. Suspend cell pellet with calculated volume. Place in Styrofoam box with ice along with thawed 
Fibrinogen and Thrombin aliquots. 
12. Place samples on Pluronics-coated side of PDMS around 1 cm apart. Secure samples by pressing 
down lightly only on the frames. 
13. Cast gels onto constructs (formula casts 2 gels, 350 μL total): 
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a. Combine 238 μL of cell suspension and 98 μL Fibrinogen inside a centrifuge tube. 
Prepare a pipette set to 175 μL for next step. 
b. Add 14 μL of Thrombin and quickly mix with pipette. Transfer 225 μL of gel onto each 
sample, spreading gel evenly across threads. 
c. Transfer PDMS with gel samples in the 1-well plate to incubator to polymerize for 30 
minutes. 
14. When samples are done polymerizing, place 6 in control 6-well plate and fill with 3mL of media. 
Fill humidity wells with 6mL of sterile water. Move plate to incubator. 
15. Take other six samples and place into another 6-well plate. Fill with media and humidity wells 
like control, and place sterilized device modified cover on plate. Place into the 3D printed device 
holder that is sprayed into the hood with 70% Ethanol. Put on sterilized acrylic cover and attach 
CO2 tubing and filter. 
16. Move device containing the sample plate to the benchtop and quickly connect to device control 
system following the user manual. Run the Arduino control system code. 
17. Monitor the serial output over the 8+ hours occasionally to verify that the control system is 
functioning normally. Do not open the device parts containing samples to maintain the internal 
sterile environment. 
18. After 8 hours follow Example Dilution Protocol of LIVE/DEAD stain kit to make 10 mL of 2 μM 
calcein AM and 4 μM EthD-1 solution: 
a. Remove reagents from freezer and allow thawing to room temperature. Keep away from 
light for rest of procedure by wrapping in aluminum foil or turning off hood light. 
b. Add 20 μL of EthD-1 stock to 10mL of sterile DPBS and vortex. 
c. Transfer 5 μL of Calcein AM stock to the 10 mL Ethd-1 solution and vortex. 
19. Rinse samples with DPBS then add 2.5 mL of the stain solution to each sample well. Incubate for 
30 minutes to set stain. 
20. Image with fluorescent microscopy in four areas per sample. Record results. 
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Appendix S: User Manual  
 
 
User Manual for Use and 
Maintenance of Microscope 
Incubator Device 
April 2017 
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1. Assembly 
1.1 Holder Set-Up 
 
1. To begin assembling the device, obtain a 6-well plate and discard the cover. 
2. Take the 3-D printed holder and place on benchtop. Place the two sliding walls in the holder on both 
ends.  
3. The wall with a groove on the bottom will be placed at the front of the device. This slot allows for the 
thermistor to come out of the device. In the front of the device, there is also a slot for the transparent 
heater to be placed under the holder. Note: The transparent heater should be placed under the holder so 
that the soldered side is facing up.  
4. Place the 6-well plate in the holder then screw it in place making sure it is level and completely against 
the transparent heater. Note: The 6-well plate should be oriented so that the beveled edges are located at 
the front of the device.  
5. Place the modified cover on top. Place perfusion assembly attached to the cover in the correct slots. 
Place the acrylic cover with the tubing for CO2 gas on top. See Section 1.2 for full set up.   
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Thermistor Hole 
Transparent Heater Location 
3b 
4a 
4b 
Front of Device Front of Device 
3a 
Place Soldered 
Side Up 
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1.2 Sensor Set-Up 
 
1. Slide the CO2 sensor into the back left side of the holder, with the wiring remaining outside of it.  
2. The thermistor, which is attached to the modified cover needs to have its wiring placed in the groove at 
the bottom of the sliding wall.  
3. Completed sensor and holder set-up.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1a 1b 
2a 2b 
164 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Perfusion Set-Up 
The perfusion system is already connected to the modified cover, however, if replacements ever 
need to be made, the procedure can be found in Section 5.2.  
 
 
 
3 
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1.4 CO2 Canister and Arduino Connection Set-Up 
 
1. Connect the 4 wires from the CO2 sensor to the four corresponding colored wires connected to the 
Arduino.  
2. Connect the 2 blue clips to the 2 blue clips coming from the Arduino. These clips are labelled 1 and 2 
to ensure proper connection.  
3. Connect the HEPA filter and tubing that is coming from the acrylic cover of the device to the CO2 
canister tubing.  
4. Shows full set-up.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
2 
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2. Use 
 
2.1 Assembly Changes 
 Once the device assembly is completed, the screws on the side of the device can be 
tightened or untightened as desired.  
o Note: Make sure the 6-well plate remains in contact with the heater whenever 
tightening the screws 
 To move the system to another area of the lab, undo all connections to the Arduino, 
tighten all screws, and lift holder. This should leave only the transparent heater on the 
benchtop or microscope. 
2.2 Humidity 
 At the start of an experiment, fill each humidity well with 3mL of water.  
 There should be enough water for at least 8 hours of humidity while the device is in use.  
If the device is use for longer, check regularly for water level and add water when 
necessary. If the humidity basin is close to empty, the acrylic lid and 6-well cover will 
have to be removed and the water can then be added. This should be done in a sterile 
environment.  
2.3 CO2 Sensor 
 The CO2 sensor is factory set to recalibrate every 24 hours. It calibrates the lowest 
reading in the previous 24hour period to atmospheric level which is undesired. Because 
of this, the sensor should be unplugged at least once every 24 hours to avoid the self-
calibration.   
 The CO2 sensor should be recalibrated every 3 years according to the manufacturer. To 
do this, hit the calibration button on the I2C board for three seconds while in normal 
atmospheric conditions.  
 
3. Sterilization 
Materials to be EtO Sterilized:  
 Modified Cover with injection luer locks 
 Tubing with HEPA filter attached 
 Acrylic Cover 
Materials to be Autoclaved:  
 Media  
 Syringes x2 (3mL) 
 Needles (for perfusion)   
 DI water for humidity wells  
Materials to be sprayed down into hood:  
 3D Printed Holder  
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4. Replacements and Maintenance 
4.1. Cleaning 
The acrylic cover and transparent heater will acquire smudges and fingerprints over time. In order 
to remove them, isopropanol can be used with paper towels to wipe them clean. 
4.2. CO2 Canister Replacement 
As the regulator on the CO2 system approaches zero, the canister will have to be replaced. When 
this occurs, the old canister must be removed and a 1L CO2 canister must be purchased from ISTA and 
connected to the regulator/solenoid setup as shown below. 
 
 
4.3 Calibrating a New Thermistor 
If the thermistor should break for any reason, a new one can be purchased and calibrated.  
After obtaining a water-proof thermistor, a calibration curve must be created. The resistance of 
the thermistor will increase as temperature decreases, but not in a linear fashion. In order to achieve this 
curve, a mercury thermometer, a cup of ice, and a cup of hot water must first be obtained.  
Placing both the thermometer and thermistor in the cup of ice, the temperature and resistance of 
the thermistor should be recorded after. Slowly placing hot water into the cup, temperature and resistance 
should be recorded periodically, creating the curve. Each reading should only be taken after the 
temperature becomes stable and readings should be taken more frequently in the functioning range of the 
device (~30-40°C) to obtain higher accuracy.  
With this data, a quadratic trendline should be added to obtain the equation relating the 
temperature to the resistance. This equation is what is used in the Arduino code to "translate" the 
resistance of the thermistor to the corresponding temperature. Update the code accordingly. 
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4.4 Perfusion Assembly 
If any of the tubing or luer lock connections need to be replaced, follow these instructions: 
Tubing size:  
 inner diameter: 0.86 mm 
 outer diameter: 1.27 mm 
The perfusion system is made up of four components that connect to each other as shown in the 
figure below. Once this is set up, place Loctite tape over connection sites between 1 and 2 and between 2 
and 3. Next, place the tubing from each luer lock system into the designated holes on the top of the 
modified 6-well plate cover. With the tubing in each well fully inserted, place each luer lock component 
in the corresponding grooves on the sides of the holder. Add additional Loctite tape to secure the tubing 
in place on the cover.  
 
Perfusion System Assembly. a) Components: (1) tubing (2) tubing luer lock connector (3) female luer lock connector, and (4) 
injectable male luer lock. b) Assembled luer lock 
5. Safety 
 Needle for perfusion 
o Keep covers on them. Only remove needle covers right before puncturing to avoid 
accidents. 
o Wear gloves 
o Keep a clean and non-messy bench area 
 Electrical Components 
o Keep all components away from water  
o Make sure metal wire connections aren't touching each other in box. 
o Before moving/touching electrical components, make sure all wall outlets are NOT 
plugged in.  
o The solenoid functions on 120 VAC. It is contained in casing shown below. Avoid 
touching inner components. 
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6. Arduino Code  
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Arduino Code Concept Map: 
 
 
Notes: 
 If CO2 level and temperature readings are to be recorded, the Arduino must be connected to a 
laptop. Open the Arduino code. Go to ToolSerial Monitor.  
 Update lines 79 and 126 if a new thermistor is calibrated.  
 To change the desired CO2 range, update lines 103 and 155. 
 To change the desired temperature range, update lines 138, 141, 157, and 160.  
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7. Circuit Diagrams 
Thermistor Wiring
THERMISTOR
Resistor, 10k
To Arduino
Vcc (5V)
GND
BLK
Temp 
Sensor
Pin #A1
Analog Input:  temp_control
RED
ORG
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7.1 Specifications for TN2-5V Relay 
 
Reference: 
Slim Polarized Relay TN Relay. Panasonic. Matsushita Electric Works, Ltd. [Data Sheet].  
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7.2 Specifications for MH-Z16 CO2 Sensor 
 
Reference: 
MH-Z16 NDIR CO2 Sensor with I2C/UART Interface Board. (2015). Sandbox Electronics. Retrieved 
May 1, 2017 from http://sandboxelectronics.com/?p=1126.  
 
7.2.1 Overview 
 
 
7.2.2 Features 
 
 
7.2.3 Pin Configuration 
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7.2.4 Technical Details 
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7.3 Specifications for NTC Thermistor 
 
Product Name: Waterproof Temperature Thermal Thermistor TC 10K Probe Sensor 40cm 
Head Size: 17 x 4mm 
Resistance: 10K NTC Probe 
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7.4 Specifications for Transparent Heater from Thin Film Devices 
    
ITEM                         DESCRIPTION                      
   
 APPLICATION: SOLAR CELL / OPV / Electro Chem. / Oled  
 Manufacture and coat per the following:  
    
1. Substrate:         TFD Supplied   
 Material:          Eagle XG  
 Dimensions:            15mm x 15mm ± 0.2mm  
 Thickness: 0.7mm  
 Surface: 60/40  
 Edges: Scribe/Break   
    
2. COATING: Side 1   
 Material: ITO   
 Thickness: 1450 ± 100Å  
 Resistivity: 20 ± 2 ohms/sq.  
 Transmission: 88% @ 550nm  
 Coating Defects: 60/40  
 Method: Sputtering  
 Non-Uniformity: ± 2.5% across 14” x 18”  
 Tooling Mark: None  
    
 NOTE: 1.Surface Roughness of ITO ≤ 7Å RMS  
  @ 1450Å  
  2.Work Function = -4.8eV -> -5.0eV  
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8. Material List and Part Numbers 
 
Item Description Supplier Part Number 
6-Well Plate Falcon 08-772-33 
Epoxy Coated Thermistor Uxcel TC 10K 
NDIR CO2 Sensor Sandbox Electronics MH-Z16 
Arduino Uno Board DigiKey A000066 
Transparent Heater Thin Film Devices Custom Order 
Professional C02 Supply Set - 1L ISTA 00677 
.86mm ID Tubing Polyethylene Intraguard 427421 
Male Luer Lock Injection Site connectors Qosina 80149 
Female Luer Lock to Barb Qosina LF5130 
Male Luer Lock Plug Cole-Parmer UX-45505-56 
Go2 Clear Repair Wrap 1in by 7.5ft Loctite 1872161 
Slim Polarized Relay Panasonic TN2-5V 
In Line Filter Dickson Homebrew FIL90X1 
18 in. x 24 in. x 0.093 in. Clear Acrylic 
Sheet Glass Replacement 
Home Depot MC-05 
 
 
 
 
 
 
 
 
 
 
